<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s43141-023-00530-9</query><apiKey>87ba7cb21f89ce78154df796840621f4</apiKey><result><total>1</total><start>1</start><pageLength>2</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="publisher-id">43141</journal-id><journal-title-group><journal-title>Journal of Genetic Engineering and Biotechnology</journal-title><abbrev-journal-title abbrev-type="publisher">J Genet Eng Biotechnol</abbrev-journal-title></journal-title-group><issn pub-type="epub">2090-5920</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s43141-023-00530-9</article-id><article-id pub-id-type="manuscript">530</article-id><article-id pub-id-type="doi">10.1186/s43141-023-00530-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Characterization of biologically active exopolysaccharide produced by <italic>Streptomyces</italic> sp<italic>.</italic> NRCG4 and its anti-Alzheimer efficacy: in-vitro targets</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Mahmoud</surname><given-names>Manal G.</given-names></name><address><email>gomaa001@yahoo.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au2"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5155-3949</contrib-id><name><surname>Awady</surname><given-names>Mohamed E. El</given-names></name><address><email>mohamed.elawady82@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="corresp" rid="IDs43141023005309_cor2">b</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Selim</surname><given-names>Manal S.</given-names></name><address><email>manalsleem@yahoo.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Ibrahim</surname><given-names>Abeer Y.</given-names></name><address><email>abeeryousry@yahoo.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au5"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8769-9667</contrib-id><name><surname>Ibrahim</surname><given-names>Faten M.</given-names></name><address><email>fatenmibrahim@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Mohamed</surname><given-names>Sahar S.</given-names></name><address><email>sahar2009sm@yahoo.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.419725.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2151 8157</institution-id><institution content-type="org-division">Microbial Biotechnology Department</institution><institution content-type="org-name">National Research Centre</institution></institution-wrap><addr-line content-type="street">33 Bohouth St</addr-line><addr-line content-type="postcode">12622</addr-line><addr-line content-type="city">Dokki, Giza</addr-line><country country="EG">Egypt</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.419725.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2151 8157</institution-id><institution content-type="org-division">Medicinal and Aromatic Plants Research Department, Pharmaceutical and Drug Industries Research Institute</institution><institution content-type="org-name">National Research Centre</institution></institution-wrap><addr-line content-type="street">33 Bohouth St, Dokki</addr-line><addr-line content-type="postcode">12622</addr-line><addr-line content-type="city">Giza</addr-line><country country="EG">Egypt</country></aff></contrib-group><author-notes><corresp id="IDs43141023005309_cor2"><label>b</label><email>mohamed.elawady82@gmail.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>4</day><month>7</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2023</year></pub-date><volume>21</volume><issue seq="76">1</issue><elocation-id>76</elocation-id><history><date date-type="registration"><day>20</day><month>6</month><year>2023</year></date><date date-type="received"><day>25</day><month>7</month><year>2022</year></date><date date-type="accepted"><day>20</day><month>6</month><year>2023</year></date><date date-type="online"><day>4</day><month>7</month><year>2023</year></date></history><permissions><copyright-statement content-type="compact">© The Author(s) 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract xml:lang="en" id="Abs1"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">Exopolysaccharides are extremely powerful molecules with a wide range of uses in pharmaceuticals due to their structural and compositional complexity. Marine microorganisms often produce bioactive substances with novel functions and structures because of their special living conditions. Polysaccharides from marine microorganisms are of interest to new drug discovery.</p></sec><sec id="ASec2"><title>Results</title><p id="Par2">The current research focused on the isolation of bacteria from Red Sea, Egypt, that have the ability to produce a new natural exopolysaccharide in order to be examined in treating Alzheimer’s illness to obviate side effects of synthetic drugs. Properties of exopolysaccharide (EPS) produced by an isolated <italic>Streptomyces</italic> strain were investigated for its capability to play as anti-Alzheimer. This strain was identified morphologically, physiologically, and biochemically and actually was confirmed by molecularly 16S rRNA analysis as <italic>Streptomyces</italic> sp. NRCG4 with accession number MK850242. The produced EPS was fractionated by precipitation 1:4 volumes of chilled ethanol and the third major fraction (1:3) listed as NRCG4, and then the functional groups, MW, and chemical evaluation have been detected via Fourier-transform infrared (FTIR), high-performance gel permeation chromatography (HPGPC), and high-performance liquid chromatography (HPLC). The findings showed that NRCG4 was an acidic EPS composed of mannuronic acid, glucose, mannose, and rhamnose in a molar ratio of 1.2:1.5:2.8:1.0, respectively. NRCG4 Mw was determined to be 4.25 × 10<sup>5</sup> gmol<sup>−1</sup> and the Mn to be 1.97 × 10<sup>5</sup> gmol<sup>−1</sup>. Also, the NRCG4 included uronic acid (16.0%) and sulfate (0.0%), but no protein was found. In addition, antioxidant and anti-inflammation activity was measured through various methods. This study confirmed that NRCG4 exopolysaccharide exerted anti-Alzheimer’s characters via inhibition of cholinesterase and tyrosinase as well as anti-inflammatory and antioxidant abilities. Additionally, it occurred a potential role in the suppression of Alzheimer’s disease risk factors through its antioxidant (metal chelation, radical scavenging capability), anti-tyrosinase and anti-inflammatory characteristics. The anti-Alzheimer’s disease efficacy of NRCG4 exopolysaccharide may be assigned to its unique determined chemical composition.</p></sec><sec id="ASec3"><title>Conclusions</title><p id="Par3">The present study highlighted those exopolysaccharides could be harnessed to improve pharmaceutical industry (anti-Alzheimer, anti-tyrosinase, anti-inflammatory, and antioxidant agents).
</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Exopolysaccharide</kwd><kwd><italic>Streptomyces</italic></kwd><kwd>Anti-Alzheimer</kwd><kwd>Anti-tyrosinase</kwd><kwd>Anti-inflammatory</kwd><kwd>Antioxidant</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>National Research Centre</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">11010319</award-id><principal-award-recipient><name><surname>Ibrahim</surname><given-names>Abeer Y.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>Springer</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>76</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2023</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>Academy of Scientific Research and Technology</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2023</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2023</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>6</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>20</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/43141_2023_Article_530.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Engineering</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Biomedical Engineering and Bioengineering</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Genetic Engineering</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Biotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Genetics and Genomics</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Proteomics</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Bioinformatics</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Engineering</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec2"><title>Background</title><p id="Par22">Natural products and their derivatives account for more than half of all medications used in modern medicine. Conventional drug research and development is highly expensive and complex due to the low success rate and large capital investment requirements. Exopolysaccharides (EPSs) produced from microorganisms can contribute in treating various diseases. In recent decades, major attention has been focused on naturally produced polysaccharides, due to changes in monosaccharide composition and sequence, type of linkage, polymerization, and branching degree. Microbial EPSs displayed a wide range of physicochemical and rheological properties. This range of features drew attention to the industrial potential of EPSs in various fields [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. They were documented for various activities; they were reported as antioxidant agent, cyclooxygenases inhibitor that recommend their role as anti-inflammatory agent [<xref ref-type="bibr" rid="CR3">3</xref>], acetylcholinesterase inhibitors [<xref ref-type="bibr" rid="CR4">4</xref>], and anti-Alzheimer’s agent [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Approximately 75% and 60% in respect to 70% of known compounds had been produced by actinomycetes that are employed in agriculture and medicine, respectively [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Streptomycetes’ heredity, growth, and metabolic regulation have all become research centers in recent years. As a result, streptomycetes are the most commonly observed bacteria in the fermentation of active pharmaceutical drugs [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Alzheimer’s disease (AD) is a terrible neurodegenerative disorder characterized by memory and cognition loss, difficulty completing daily activities, and a variety of behavioral and neuropsychiatric diseases [<xref ref-type="bibr" rid="CR10">10</xref>]. AD is the most frequent form of dementia in the elderly. Every 5 years of age, the percentage of people with Alzheimer’s disease increases by a factor of two. As a result, the disease affects 1% of 60-year-olds and 30% of 85-year-olds. Cell loss, abundant neurofibrillary tangles, dystrophic neuritis, amyloid precursor protein, amyloid deposits, increased activation of pro-death genes and signaling pathways, impaired energy metabolism, mitochondrial dysfunction, chronic oxidative stress, and DNA damage are all hallmarks of Alzheimer's [<xref ref-type="bibr" rid="CR11">11</xref>]. This work was designed to evaluate the capacities of naturally produced exo-polysaccharide in facing Alzheimer’s disease risk factors with characterization of the produced polysaccharide and identification of its microbial source.</p></sec><sec id="Sec3" sec-type="methods"><title>Methods</title><sec id="Sec4"><title>Chemicals</title><p id="Par23">1,1-Diphenyl-2-picryl-hydrazyl (DPPH), polyoxyethylene sorbitan monolaurate (Tween-20), ascorbic acid (vitamin C), butylated hydroxytoluene (BHT), peroxidase, H<sub>2</sub>O<sub>2</sub>, ABTS (2, 2-azino-bis (3-ethylbenz-thiazoline-6-sulfonic acid)), nicotinamide adenine dinucleotide (NADH), nitroblue tetrazolium (NBT), phenazine methosulphate (PMS), sodium nitroprusside (SNP), sulfanilamide, ortho-H<sub>3</sub>PO<sub>4</sub>, naphthylethylene diamine dihydrochloride, diammonium salt, 3-(2-pyridyl)-5,6-bis (4-phenyl-sulfonic acid)-1,2,4-triazine (ferrozine), ferrous chloride, trichloroacetic acid (TCA), potassium ferricyanide, Leuco-2,7-dichlorofluorescien diacetate, hematin, arachidonic acid, cyclooxygenases enzymes (COX-1 from sheep, EC. 1.14.99.1 or human COX-2), acetylcholinesterase enzyme (EC No. 3.1.1.7) type VI-S (from electric eel), acetylthiocholine iodide, 5,5-dithiobis(2-nitrobenzoic acid) (DTNB), butyryl thio-choline iodide, human butyrylcholinesterase enzyme, kojic acid, tyrosinase enzyme, and L-Dopa were purchased from Sigma-Aldrich, USA. Ammonium thiocyanate was purchased from E. Merck. All chemicals and solvents are of analytical grade.</p></sec><sec id="Sec5"><title>Sampling and isolation of streptomycetes</title><p id="Par24">Sample was collected from the sediment of the shore (1 cm depth) of the Red Sea, Hurghada (El-Giftoun Island), Egypt. Sample was serially diluted according to Hayakawa and Nonomura [<xref ref-type="bibr" rid="CR12">12</xref>] and plated on starch nitrate agar medium containing (g/l): starch 10, K<sub>2</sub>HPO<sub>4</sub> 1.0, MgSO<sub>4</sub>.7H<sub>2</sub>O 0.5, NaCl 0.5, KNO<sub>3</sub> 2.0, CaCO<sub>3</sub> 2.0, FeSO<sub>4</sub>.7H<sub>2</sub>O 0.01, agar 20.0 which were dissolved in 750 ml sea water then completed to 1L with 250 ml distilled water, pH 7 [<xref ref-type="bibr" rid="CR13">13</xref>]. Colonies’ appearance on agar plates was selected for exo-polysaccharide (EPS) production [<xref ref-type="bibr" rid="CR14">14</xref>]. Further, the actinomycetes isolates were streaked onto starch nitrate agar medium and incubated at 30 °C for 48 h. The <italic>Streptomyces</italic> isolates were selected and picked up based on the morphological features of colonies.</p></sec><sec id="Sec6"><title>Production, extraction, and purification of EPS</title><p id="Par25">A loop was full of the strain G4 was inoculated into a 250-ml conical flask containing 50 ml of broth medium containing (g/l) glucose 10.0, tryptone 5.0, yeast extract 5.0, K<sub>2</sub>HPO<sub>4</sub> 3.0, NaCl 3.0, KH<sub>2</sub>PO<sub>4</sub> 1.0, MgSO<sub>4</sub>.7H<sub>2</sub>O 0.5, and CaCO<sub>3</sub> 0.5 which were dissolved in 750-ml sea water then completed to 1L with 250-ml distilled water, pH 7 [<xref ref-type="bibr" rid="CR15">15</xref>]. This inoculated medium was then incubated on a shaker at 120 rpm for 5 days at 28 °C. The cell-free culture supernatant was obtained by centrifugation at 3466 × <italic>g</italic> for 20; the supernatant was mixed with trichloroacetic acid (TCA) (10%) and keeping it overnight at 4 °C under static conditions, left overnight at 4 °C. Then, centrifuged at 3466 × <italic>g</italic> for 20 min to remove protein and the pH of supernatant was neutralized to 7 with NaOH solution [<xref ref-type="bibr" rid="CR16">16</xref>]. The EPS-containing solution was completed to 4 volumes with cold absolute ethanol and kept at 4 °C overnight for allowing precipitation of EPS. The precipitated EPS were separated by centrifugation at 3466 × g for 20 min and re-suspended in deionized water then washed twice, and re-precipitated by 4 volume of cold absolute alcohol and dried at 50 °C. For fractionation and major fraction determination, absolute cold ethanol was added 1, 2, 3, and 4 volumes gradually and the precipitated EPS was collected up to date. The major fraction which obtained by three volume was dialyzed against distilled water for 72 h, washed twice with acetone, dehydrated by ether, dried at 40 °C, and named as NRCG4 [<xref ref-type="bibr" rid="CR17">17</xref>]. The NRCG4 fraction powder was used for structural characterization studies and biological activities.</p></sec><sec id="Sec7"><title>Identification of EPS-producing bacterium</title><p id="Par26">The potential EPS-producing isolate G4 was selected based on promising EPS secretion on plate and identified by their morphological, physiological, and biochemical features [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR22">22</xref>] and was confirmed by 16S ribosomal RNA gene technique (16S rRNA). Genomic DNA was extracted from log-phase grown strain G4 by using the modified method of Sharma and Singh [<xref ref-type="bibr" rid="CR23">23</xref>]. The bacterial genome was isolated and 16 s rRNA gene was amplified using polymerase chain reaction technique using the following primers F-(5′-GAGTTTGATCCTGGCTCAG-3′) and R-(5′-GGTTACCTTGTTACGACTT-3′) based on Gardes and Bruns [<xref ref-type="bibr" rid="CR24">24</xref>] method. Sequencing was performed by using Big Dye terminator cycle sequencing kit (Applied BioSystems, USA). Sequencing products were resolved on an Applied Bio-systems model 3730XL automated DNA sequencing system (Applied BioSystems, USA). The resulting 16 s rRNA sequence was submitted to GenBank database and compared with the other 16S rRNA sequences in the National Center for Biotechnology Information (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/</ext-link>) using the BLAST program. The sequence of other bacterial strains with the greatest similarity to the 16 s rRNA gene of our isolate was selected and aligned for making the suitable phylogenetic tree. The 16 s rRNA gene sequence of our isolate was deposited in the DDBJ/EMBL/GenBank nucleotide sequence databases.</p></sec><sec id="Sec8"><title>Chemical analysis of NRCG4</title><p id="Par27">NRCG4 was subjected to complete acid hydrolysis with formic acid (88%) in a sealed tube at 100 °C for 5 h. The sulfate content was estimated by turbidity method using Barium Chloride-Tween 80 reagent according to Dodgson and Price [<xref ref-type="bibr" rid="CR25">25</xref>]. Uronic acid content was spectrophotometrically analyzed at 525 nm (2401PC 750 Lambda Double Beam UV–Vis; Spectrophotometer Shimadzu, Kyoto, Japan) following the <italic>m-</italic>hydroxybiphenyl colorimetric method [<xref ref-type="bibr" rid="CR26">26</xref>]. High-performance liquid chromatography (HPLC, Agilate Pack, serics1, 200), equipped with Aminex carbohydrate HP-87C column (300 × 7.8 mm), was applied for monosaccharide composition and calculation of molar ratio using deionized water as a mobile phase at flow rate 0.5 ml/ min [<xref ref-type="bibr" rid="CR27">27</xref>]. The mass average molar weight (<italic>Mw</italic>) of NRCG4 was determined by high-performance gel permeation chromatography (HPGPC, Agilent 1100 Series System, Hewlett-Packard, Germany) with refractive index (<italic>RI</italic>) detection [<xref ref-type="bibr" rid="CR28">28</xref>]. The number average molar mass (<italic>Mn</italic>) was determined and polydispersity index (<italic>PI</italic>) was calculated from (<italic>Mw/Mn</italic>) ratio. Therefore, dried NRCG4 (2 mg) was mixed with 200 mg KBr powder, then pressed to form a 1-mm pellet for FTIR spectrum measurement in the range between 400 and 4000 cm<sup>−1</sup> using FTIR-UNIT Bruker Vector 22 Spectrophotometer [<xref ref-type="bibr" rid="CR29">29</xref>].</p></sec><sec id="Sec9"><title>Acetyl cholinesterase inhibition efficacy assay</title><p id="Par28">NRCG4 were subjected to determine acetyl cholinesterase inhibition efficacy. The enzymatic activity was measured using an adaptation of the method described in Ingkaninan et al. [<xref ref-type="bibr" rid="CR30">30</xref>]. Five hundred microliters of DTNB (3 mM), 100μL of AChI (15 mM), 275 μL of Tris–HCl buffer (50 mM, pH 8), and 100μL of NRCG4 at 25, 50, 100, 200, and 400 μg ml<sup>−1</sup> were added to a 1 ml and was used as blank. In the reaction, 25 μL of buffer was replaced by the same volume of an enzyme solution containing 0.28 Uml<sup>−1</sup>. The reaction was monitored for 5 min at 405 nm. Velocities of reaction were calculated. Enzyme activity was calculated as a percentage of the velocities compared to that of the assay using buffer instead of tested inhibitor NRCG4. Inhibitory activity was calculated from 100 subtracted by the percentage of enzyme activity. Data presented here are the average of three replicates. Eserine hemi sulfate salt was used as positive control and it was tested at different concentrations different from samples. The tested eserine concentrations were 0.01, 0.02, 0.04, and 0.08 μg ml<sup>−1</sup> [<xref ref-type="bibr" rid="CR31">31</xref>].</p></sec><sec id="Sec10"><title>Butyrylcholinesterase inhibitory assessment</title><p id="Par29">Enzymatic activity was analyzed using an adaptation of the method of Ingkaninan Orhan et al. [<xref ref-type="bibr" rid="CR30">30</xref>]. In sum, 500 μL of the DTNB (3 mM), 100 μl of butyryl thiocholine iodide (15 mM), 275 μl of Tris–HCl buffer (50 mM, pH 8), and 100 μl NRCG4 at different concentrations (25, 50, 100, 200 and 400 μg/ ml) was dissolved in ethyl alcohol (HPLC grade) and was added to a 1 ml cuvette then was used as a blank. In the reaction cuvette, 25 μl of Tris–HCl buffer was replaced by the same volume of butyrylcholinesterase enzyme solution containing 0.28 U ml<sup>−1</sup>. The color developed was monitored for 5 min at 405 nm. The percent of inhibition was calculated.</p><p id="Par30"> <disp-formula id="Equa"><alternatives><mml:math display="block" id="Equa_Math"><mml:mrow><mml:mi mathvariant="normal">Controlabsorbance</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant="normal">sampleabsorbance</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">/</mml:mo><mml:mi mathvariant="normal">controlabsorbance</mml:mi><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math><tex-math id="Equa_TeX">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym}
				\usepackage{amsfonts}
				\usepackage{amssymb}
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Controlabsorbance}-\mathrm{sampleabsorbance})/\mathrm{controlabsorbance}\times100.$$\end{document}</tex-math><graphic specific-use="web" mime-subtype="GIF" xlink:href="43141_2023_530_Article_Equa.gif"/></alternatives></disp-formula></p><p id="Par31">The IC<sub>50</sub> was calculated by log-probit analysis. Eserine served as a positive control [<xref ref-type="bibr" rid="CR32">32</xref>].</p></sec><sec id="Sec11"><title>Anti-tyrosinase activity assessment</title><p id="Par32">Tyrosinase inhibition assay (EC1.14.18.1) was performed according to the methods of Liu et al. [<xref ref-type="bibr" rid="CR33">33</xref>] with slight modifications. Briefly, NRCG4 sample and kojic acid (Sigma, St. Louis, MO, USA) were dissolved in DMSO prepared as 0.1 mg/ ml. The reaction was carried out and (Jasco, serial No. C317961148, Japan) spectrophotometer was used to measure the absorbance at 475 nm. NRCG4 (40 μl each) was dissolved in methanol with 80 μl of phosphate buffer (pH 6.8), 40 μl of tyrosinase enzyme, and 40 μl of L-Dopa (Sigma, St. Louis, MO, USA) which were placed in each well. Each sample was accompanied by a blank that had all the components except for L-Dopa. Kojic acid was used as the standard inhibitor. The percentage of tyrosinase inhibition was calculated as follows:<disp-formula id="Equb"><alternatives><mml:math display="block" id="Equb_Math"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">Acontrol</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant="normal">Asample</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">/</mml:mo><mml:mi mathvariant="normal">Acontrol</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><tex-math id="Equb_TeX">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym}
				\usepackage{amsfonts}
				\usepackage{amssymb}
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\lbrack(\mathrm{Acontrol}-\mathrm{Asample})/\mathrm{Acontrol}\rbrack\times100$$\end{document}</tex-math><graphic specific-use="web" mime-subtype="GIF" xlink:href="43141_2023_530_Article_Equb.gif"/></alternatives></disp-formula>where <italic>A</italic><sub>control</sub> is the absorbance of the control reaction and <italic>A</italic><sub>sample</sub> is the absorbance of the extracts or standard, analyses were run in triplicate.</p></sec><sec id="Sec12"><title>Anti-inflammatory activity</title><p id="Par33">The cyclooxygenase inhibition efficacy NRCG4 was performed according to a modified method of Larsen et al. [<xref ref-type="bibr" rid="CR34">34</xref>] and celecoxib was used as the standard compound. The concentrations of tested materials were 5, 10, 20, 40, 80, and 100 μg/ml whereas they were in ng/ ml for standard, celecoxib, in examination against COX-2. On the other hand, the concentrations of tested materials and standard were 25, 50, 100, 200, and 400 μg/ml against COX-1. Leuco-2, 7-dichlorofluoresce in diacetate (5 mg) was hydrolyzed at room temperature in 1 M NaOH (50 μl) for 10 min, then 1 M HCl (30 μl) was added to neutralize excess NaOH before the resulting 1-DCF was diluted in 0.1 M Tris-buffer, pH 8. Cyclooxygenase enzyme (COX-1 or COX-2) was diluted in 0.1 M Tris-buffer, pH 8, so that a known aliquot gave an absorbance change of 0.05/min in the test reaction. Test samples (or the equivalent volume of methanol, 20 μl) were pre-incubated with enzyme at room temperature for 5 min in the presence of hematin. Premixed phenol, 1-DCF, and arachidonic acid were added to the enzyme mixture to begin the reaction, and to give a final reaction mixture of arachidonic acid (50 μM), phenol (500 μM), 1-DCF (20 μM), and hematin (1 μM) in 1-ml final volume of 0.1 M Tris-buffer, pH 8. The reaction was recorded spectrophotometrically over 1 min at 502 nm. A blank reaction mixture was analyzed in the spectrophotometer reference cell against each test reaction to account for any non-enzymatic activity attributed to the test sample. This blank consisted of the reaction mixture without the addition of enzyme.</p></sec><sec id="Sec13"><title>Antioxidant activities</title><sec id="Sec14"><title>Free radical scavenging characters</title><sec id="FPar1"><title>DPPH radical scavenging activity</title><p id="Par34">According to the method of Ibrahim et al. [<xref ref-type="bibr" rid="CR35">35</xref>] the free radical scavenging activity of NRCG4 using 1,1-diphenyl-2-picryl-hydrazil (DPPH·). DPPH· (0.1 mM) was prepared in methanol. Successive concentration from polysaccharide and standard materials; BHT and Ascorbic Acid were prepared as 25, 50, 100, 200, and 400 μg/ ml in methanol. One milliliter of DPPH· solution was added to 3 ml of each concentration, and then the mixture was shaken vigorously and was allowed to stand at room temperature for 30 min. Control was assayed with the same procedure, except methanol was instead sample. The absorbance was read at 517 nm in a spectrophotometer (Jasco, serial No. C317961148, Japan). According to the following equation, DPPH radical scavenging activity was calculated:<disp-formula id="Equc"><alternatives><mml:math display="block" id="Equc_Math"><mml:mrow><mml:mi mathvariant="normal">DPPH</mml:mi><mml:mo>·</mml:mo><mml:mi mathvariant="normal">scavengingeffect</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>0</mml:mn><mml:mo>-</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">/</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo stretchy="false">]</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:math><tex-math id="Equc_TeX">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym}
				\usepackage{amsfonts}
				\usepackage{amssymb}
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{DPPH}\cdot\mathrm{scavengingeffect}(\%)=\lbrack(\mathrm A0-\mathrm A1)/\mathrm A0)\times100\rbrack.$$\end{document}</tex-math><graphic specific-use="web" mime-subtype="GIF" xlink:href="43141_2023_530_Article_Equc.gif"/></alternatives></disp-formula>where <italic>A</italic><sub>0</sub> was the absorbance of the control and <italic>A</italic><sub>1</sub> was the absorbance in the presence of the sample of polysaccharide.</p></sec></sec></sec><sec id="Sec15"><title>ABTS radical cation scavenging activity</title><p id="Par35">Based on the method described by Miller and Rice-Evans [<xref ref-type="bibr" rid="CR36">36</xref>] and modified by Arnao et al. [<xref ref-type="bibr" rid="CR37">37</xref>], ABTS radical cation scavenging activity of NRCG4 polysaccharide at different concentrations was estimated and was compared with two standard materials: BHT and ascorbic acid at the same concentrations. Reaction was prepared by adding 0.2 ml of peroxidase (4.4units/ ml), 0.2 ml of H<sub>2</sub>O<sub>2</sub> (50 μM), and 0.2 ml of ABTS (100 μM) and 1-ml methanol mixed and kept in the dark for 1 h to form a bluish green complex. After dark incubation period, 1 ml of polysaccharide, BHT, and ascorbic Acid at different concentrations were added. Control was prepared by the same procedure without samples. The absorbance at 734 nm was measured to represent the ABTS radical cation scavenging activity and then was calculated as follows:<disp-formula id="Equd"><alternatives><mml:math display="block" id="Equd_Math"><mml:mrow><mml:mi mathvariant="normal">ABTS</mml:mi><mml:mspace width="0.277778em"/><mml:mi mathvariant="normal">radical</mml:mi><mml:mspace width="0.277778em"/><mml:mi mathvariant="normal">cation</mml:mi><mml:mspace width="0.277778em"/><mml:mi mathvariant="normal">scavenging</mml:mi><mml:mspace width="0.277778em"/><mml:mi mathvariant="normal">activity</mml:mi><mml:mspace width="0.277778em"/><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">Asample</mml:mi><mml:mo stretchy="false">/</mml:mo><mml:mi mathvariant="normal">Acontrol</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math><tex-math id="Equd_TeX">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym}
				\usepackage{amsfonts}
				\usepackage{amssymb}
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{ABTS}\;\mathrm{radical}\;\mathrm{cation}\;\mathrm{scavenging}\;\mathrm{activity}\;(\%)=\lbrack1-(\mathrm{Asample}/\mathrm{Acontrol})\rbrack\times100.$$\end{document}</tex-math><graphic specific-use="web" mime-subtype="GIF" xlink:href="43141_2023_530_Article_Equd.gif"/></alternatives></disp-formula></p></sec><sec id="Sec16"><title>Lipid peroxidation in ammonium thiocyanate medium</title><p id="Par36">The ability of NRCG4 to inhibit lipid peroxidation was determined according to the method of Gulcin et al. [<xref ref-type="bibr" rid="CR38">38</xref>] with some modifications and was compared with BHT and ascorbic acid to evaluate it. A pre-emulsion was prepared by mixing 175 μg Tween 20, 155 μl linoleic acid, and 0.04 M potassium phosphate buffer (pH 7.0). One milliliter of sample in 99.5% ethanol was mixed with 4.1 ml linoleic emulsion, 0.02 M phosphate buffer (pH 7.8), and distilled water (pH 7.9). The mixed solutions of samples (21 ml) were incubated in screw cap tubes under dark conditions at 40 °C at certain time intervals. 0.1 ml of this mixture was pipetted and added with 9.7 ml of 75% and 0.1 ml of 30% ammonium thiocyanate sequentially. After 3 min, 0.1 ml of 0.02 M ferrous chloride in 3.5% HCl was added to the reaction mixture. The peroxide level was determined by reading daily of the absorbance at 500 nm in a spectrophotometer. The inhibition of lipid peroxidation in percentage was calculated by the following equation:<disp-formula id="Eque"><alternatives><mml:math display="block" id="Eque_Math"><mml:mrow><mml:mi mathvariant="normal">Lipid</mml:mi><mml:mspace width="0.277778em"/><mml:mi mathvariant="normal">peroxidation</mml:mi><mml:mspace width="0.277778em"/><mml:mi mathvariant="normal">inhibition</mml:mi><mml:mspace width="0.277778em"/><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">/</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><tex-math id="Eque_TeX">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym}
				\usepackage{amsfonts}
				\usepackage{amssymb}
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Lipid}\;\mathrm{peroxidation}\;\mathrm{inhibition}\;(\%)=\lbrack1-(\mathrm A0)/\mathrm A1)\rbrack\times100$$\end{document}</tex-math><graphic specific-use="web" mime-subtype="GIF" xlink:href="43141_2023_530_Article_Eque.gif"/></alternatives></disp-formula>where <italic>A</italic><sub>0</sub> was the absorbance of the control reaction and <italic>A</italic><sub>1</sub> was the absorbance in the presence of polysaccharide or standard compounds.</p><sec id="Sec17"><title><bold><italic>Reduction of ferric ions (Fe</italic></bold><sup><bold><italic>3</italic></bold>+</sup><bold><italic>) power</italic></bold></title><p id="Par37">The Fe<sup>3+</sup> reducing power of NRCG4 was assayed according to the method of Oyaizu [<xref ref-type="bibr" rid="CR39">39</xref>] and was compared with BHT and ascorbic acid as standard materials. Each concentration from tested compounds was mixed with phosphate buffer (2.5 ml, 0.2 M, pH 6.6) and potassium ferricyanide [K<sub>3</sub>Fe (CN) <sub>6</sub>] (2.5 ml, 1%). The mixture was incubated at 50 °C for 20 min. 2.5 ml of TCA (10%) was added to the mixture, which was then centrifuged for 10 min at 1000 × <italic>g</italic> (MSE Mistral 2000, UK, and Serial No.: S693/02/444). The upper layer of solution (2.5 ml) was mixed with methanol (2.5 ml) and FeCl<sub>3</sub> (0.5 ml, 0.1%), and the absorbance was measured at 700 nm in a spectrophotometer.</p></sec><sec id="Sec18"><title><bold><italic>Ferrous ions (Fe</italic></bold><sup><bold><italic>2</italic></bold>+</sup><bold><italic>) chelating capacity</italic></bold></title><p id="Par38">The Fe<sup>2+</sup> chelating activity of NRCG4 was estimated according to the method of Dinis et al. [<xref ref-type="bibr" rid="CR40">40</xref>] and was evaluated by comparing with two standard compounds (BHT and ascorbic acid at the same conditions). Each concentration was added to 2 mM FeCl<sub>2</sub> (0.05 ml). The reaction was initiated by the addition of 5 mM ferrozine (0.2 ml) and the mixture was shaken vigorously and left standing at room temperature for 10 min. The control contained FeCl<sub>2</sub> and ferrozine justly. The absorbance of the reaction was read at 562 nm in a spectrophotometer. The percentage of inhibition of ferrozine-Fe<sup>2+</sup> complex formation was given by the formula:<disp-formula id="Equf"><alternatives><mml:math display="block" id="Equf_Math"><mml:mrow><mml:mi mathvariant="normal">Inhibition</mml:mi><mml:mspace width="0.277778em"/><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>0</mml:mn><mml:mo>-</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">/</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>0</mml:mn><mml:mo stretchy="false">]</mml:mo><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math><tex-math id="Equf_TeX">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym}
				\usepackage{amsfonts}
				\usepackage{amssymb}
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Inhibition}\;(\%)=\lbrack(\mathrm A0-\mathrm A1)/\mathrm A0\rbrack\times100.$$\end{document}</tex-math><graphic specific-use="web" mime-subtype="GIF" xlink:href="43141_2023_530_Article_Equf.gif"/></alternatives></disp-formula>where <italic>A</italic><sub>0</sub> was the absorbance of the control and <italic>A</italic><sub>1</sub> was the absorbance in the presence of the sample of polysaccharide and standards.</p></sec></sec><sec id="Sec19"><title>Reactive oxygen species (ROS) scavenging capacity</title><sec id="Sec20"><title>Superoxide anion scavenging activity</title><p id="Par39">Measurement of superoxide anion (O<sup>2<bold>−</bold></sup>) scavenging activity of NRCG4 was based on the method described by Liu et al. [<xref ref-type="bibr" rid="CR41">41</xref>] with slight modifications [<xref ref-type="bibr" rid="CR38">38</xref>]. O<sup>2−</sup> were generated in 3 ml of Tris–HCl buffer (16 mM, pH 8.0) containing 1 ml of NBT (50 μM) solution, 1 ml NADH (78 μM) solution and 1 ml from NRCG4 or standard materials solution at different concentrations were mixed. The reaction was started by adding 1 ml of PMS solution (10 μM) to the mixture. The reaction mixture was incubated at 25 °C for 5 min and was read at 560 nm in a spectrophotometer. Control was prepared with the same procedure without sample. O<sup>2−</sup> scavenging was calculated using the following formula:<disp-formula id="Equg"><alternatives><mml:math display="block" id="Equg_Math"><mml:mrow><mml:mi mathvariant="normal">TheO</mml:mi><mml:mn>2</mml:mn><mml:mo>-</mml:mo><mml:mi mathvariant="normal">scavenging</mml:mi><mml:mo>%</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>0</mml:mn><mml:mo>-</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">/</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mn>0</mml:mn><mml:mo stretchy="false">]</mml:mo><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math><tex-math id="Equg_TeX">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym}
				\usepackage{amsfonts}
				\usepackage{amssymb}
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{TheO}2-\mathrm{scavenging}\%=\lbrack(\mathrm A0-\mathrm A1)/\mathrm A0\rbrack\times100.$$\end{document}</tex-math><graphic specific-use="web" mime-subtype="GIF" xlink:href="43141_2023_530_Article_Equg.gif"/></alternatives></disp-formula>where <italic>A</italic><sub>0</sub> was the absorbance of the control and <italic>A</italic><sub>1</sub> was the absorbance of polysaccharide or standard samples.</p></sec><sec id="Sec21"><title>Nitric oxide radical scavenging activity</title><p id="Par40">Using sodium nitroprusside (SNP), the NO· radical scavenging activity of tested material was determined and was compared with two standard materials: BHT and Ascorbic Acid. NO· was generated from SNP in an aqueous solution at physiological pH to produce nitrite ions which were measured by the Greiss reagent [<xref ref-type="bibr" rid="CR42">42</xref>]. Greiss reagent constitutes 1% sulfanilamide in 5% ortho-H<sub>3</sub>PO<sub>4</sub> and 0.1% naphthyl ethylene diamine dihydrochloride. The reaction mixture contained from 2 ml of polysaccharide and standard compounds at different concentrations and SNP (10 mM) in phosphate-buffered saline pH 7.4 were incubated at 25 °C for 150 min. After incubation, 1-ml samples of reaction mixtures were removed and were diluted with 1 ml Greiss reagent. The absorbance of these solutions was measured at 540 nm against the corresponding blank solution.</p></sec><sec id="Sec22"><title>Statistical analysis</title><p id="Par41">The data were presented as mean ± SE. Data obtained were analyzed by ANOVA one-way and post hoc for multiple comparisons using the IBM-SPSS statistics program (version 25) at <italic>P</italic> ≤ 0.05, <italic>t</italic>-test (<italic>n</italic> = 3 replicates) was used in comparisons.</p></sec></sec></sec><sec id="Sec23" sec-type="results"><title>Results</title><sec id="Sec24"><title>Screening of streptomycetes for production of EPSs</title><p id="Par42">Streptomycetes are the most common bacteria used in the fermentation of active medicinal substances. Therefore, totally, ten isolates were from the sediment of the Red Sea, Hurghada (El-Giftoun Island), Egypt. Two isolates (G1 and G4) only could highly produce polysaccharide (NRCG1 and NRCG4) which were 6.54 and 7.76 g/ l, respectively (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Dry weight, EPSs, and productivity of EPSs of different isolates</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Samples</p></th><th align="left"><p>Dry weight (g/l)</p></th><th align="left"><p>EPS (g/l)</p></th><th align="left"><p>Productivity (%)</p></th></tr></thead><tbody><tr><td align="left"><p>G 1</p></td><td char="." align="char"><p>6.08</p></td><td char="." align="char"><p>3.32</p></td><td char="." align="char"><p>54.6</p></td></tr><tr><td align="left"><p>G 2</p></td><td char="." align="char"><p>7.76</p></td><td char="." align="char"><p><bold>6.54</bold></p></td><td char="." align="char"><p>84.2</p></td></tr><tr><td align="left"><p>G 3</p></td><td char="." align="char"><p>4.89</p></td><td char="." align="char"><p>5.03</p></td><td char="." align="char"><p>102.8</p></td></tr><tr><td align="left"><p>G 4</p></td><td char="." align="char"><p>5.8</p></td><td char="." align="char"><p><bold>7.76</bold></p></td><td char="." align="char"><p>133.7</p></td></tr><tr><td align="left"><p>G 5</p></td><td char="." align="char"><p>6.4</p></td><td char="." align="char"><p>2.33</p></td><td char="." align="char"><p>36.4</p></td></tr><tr><td align="left"><p>G 6</p></td><td char="." align="char"><p>4.6</p></td><td char="." align="char"><p>5.31</p></td><td char="." align="char"><p>115.4</p></td></tr><tr><td align="left"><p>G 7</p></td><td char="." align="char"><p>4.91</p></td><td char="." align="char"><p>2.29</p></td><td char="." align="char"><p>64.6</p></td></tr><tr><td align="left"><p>G 8</p></td><td char="." align="char"><p>5.09</p></td><td char="." align="char"><p>2.08</p></td><td char="." align="char"><p>40.8</p></td></tr><tr><td align="left"><p>G 9</p></td><td char="." align="char"><p>3.83</p></td><td char="." align="char"><p>2.75</p></td><td char="." align="char"><p>71.8</p></td></tr><tr><td align="left"><p>G 10</p></td><td char="." align="char"><p>6.36</p></td><td char="." align="char"><p>4.23</p></td><td char="." align="char"><p>66.5</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec25"><title>Examination of EPSs as inhibitors for neurotransmitters degradation</title><p id="Par43">Acetyl cholinesterase inhibition efficacy percentage was done for different concentrations of EPSs produced by streptomycetes isolates (G1 and G4). Results showed that EPS from G4 has increasing in acetyl cholinesterase inhibition activity percentage reached to 79.8% at 1000 ppm (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Acetyl cholinesterase inhibition (%) of EPSs preliminary test</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"><p>Isolates</p></th><th align="left" colspan="4"><p>Acetyl cholinesterase inhibition (%)</p></th></tr><tr><th align="left"><p>25 ppm</p></th><th align="left"><p>50 ppm</p></th><th align="left"><p>100 ppm</p></th><th align="left"><p>200 ppm</p></th></tr></thead><tbody><tr><td align="left"><p>G1</p></td><td char="." align="char"><p>7.8</p></td><td char="." align="char"><p>11.4</p></td><td char="." align="char"><p>16.2</p></td><td char="." align="char"><p>23.4</p></td></tr><tr><td align="left"><p>G4</p></td><td char="." align="char"><p>22.2</p></td><td char="." align="char"><p>34.2</p></td><td char="." align="char"><p>55.8</p></td><td char="." align="char"><p>79.8</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec26"><title>Identification of the promising streptomyces isolate</title><p id="Par44">The most isolate (NRCG4) has high acetyl cholinesterase inhibition activity which was subjected to morphological (Figs. <xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>) and physiological and biochemical characteristics (Table <xref rid="Tab3" ref-type="table">3</xref>). Whereas, the comparative analysis of ribonuclease-resistant oligonucleotides of the 16S ribosomal RNA is the most valuable technique for establishing the relatedness of higher taxa (16 s rRNA) [<xref ref-type="bibr" rid="CR43">43</xref>]. Therefore, phylogenetic analysis based on the 16S rRNA gene sequence of strain NRCG4 was compared to reference 16S rRNA quality arrangement accessible in the GenBank and EMBL database acquired from the National Centre of Biotechnology Data database utilizing BLAST search (<ext-link xlink:href="http://ncbi.nlm.nih.gov/BLAST/" ext-link-type="uri">http://ncbi.nlm.nih.gov/BLAST/</ext-link>). Therefore, it was determined to be <italic>Streptomyces</italic> sp. NRCG4 with accession number MK850242. Figure <xref rid="Fig3" ref-type="fig">3</xref> shows phylogenetic tree of the partial sequence of 16S rRNA of the local isolate <italic>Streptomyces</italic> sp. NRCG4 respects to closely related sequences found in GenBank databases. The sequences of other streptomyces strains having the highest similarity to the 16 s rRNA gene of our isolate, ranging from 92 to 100 percent, were chosen and linked to create an appropriate phylogenetic tree.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>TEM photomicrograph of G4 showing smooth spore surface</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/43141_2023_530_Fig1_HTML.png" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>Photomicrograph showing straight/flexuous sporophores hyphae</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/43141_2023_530_Fig2_HTML.png" id="MO2"/></fig><table-wrap id="Tab3"><label>Table 3</label><caption xml:lang="en"><p>Different characteristics of streptomycete isolate (G4)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="17"><p>Morphological and cultural characteristics</p></th></tr></thead><tbody><tr><td align="left" colspan="4"><p>Spore chain morphology</p></td><td align="left" colspan="4"><p>Spore surface ornamentation</p></td><td align="left" colspan="2"><p>Color of spore mass</p></td><td align="left" colspan="4"><p>Pigmentation of substrate mycelium</p></td><td align="left" colspan="3"><p>Diffusible pigment</p></td></tr><tr><td align="left" colspan="4"><p><bold>Straight/flexuous &gt; 40</bold></p></td><td align="left" colspan="4"><p><bold>Smooth</bold></p></td><td align="left" colspan="2"><p><bold>Gray</bold></p></td><td align="left" colspan="4"><p><bold>grayish white</bold></p></td><td align="left" colspan="3"><p><bold>-ve</bold></p></td></tr><tr><td align="left" colspan="17"><p>Physiological and biochemical characteristics</p></td></tr><tr><td align="left" colspan="5"><p>Melanin pigment production</p></td><td align="left" colspan="7"><p>Degradation activities</p></td><td align="left" colspan="3"><p>Nitrate reduction</p></td><td align="left" colspan="2"><p>H<sub>2</sub>S production</p></td></tr><tr><td align="left" colspan="2"><p>Peptone iron</p></td><td align="left" colspan="3"><p>Tyrosine</p></td><td align="left" colspan="2"><p>Xanthine</p></td><td align="left" colspan="2"><p>Elastin</p></td><td align="left" colspan="3"><p>Arbutin</p></td><td align="left" rowspan="2" colspan="3"><p><bold> + ve</bold></p></td><td align="left" rowspan="2" colspan="2"><p><bold> + ve</bold></p></td></tr><tr><td align="left" colspan="2"><p><bold>-ve</bold></p></td><td align="left" colspan="3"><p><bold>-ve</bold></p></td><td align="left" colspan="2"><p><bold>-ve</bold></p></td><td align="left" colspan="2"><p><bold>-ve</bold></p></td><td align="left" colspan="3"><p><bold> + ve</bold></p></td></tr><tr><td align="left" colspan="17"><p>Utilization of sugars</p></td></tr><tr><td align="left"><p> D-fructose</p></td><td align="left" colspan="2"><p>Sucrose</p></td><td align="left" colspan="3"><p>Rhamnose</p></td><td align="left" colspan="2"><p>D-mannitol</p></td><td align="left"><p>D-xylose</p></td><td align="left" colspan="2"><p>Raffinose</p></td><td align="left" colspan="2"><p>I-inositol</p></td><td align="left" colspan="3"><p>Galactose</p></td><td align="left"><p>L-arabinose</p></td></tr><tr><td align="left"><p> <bold>-ve</bold></p></td><td align="left" colspan="2"><p><bold> + ve</bold></p></td><td align="left" colspan="3"><p><bold>-ve</bold></p></td><td align="left" colspan="2"><p><bold>-ve</bold></p></td><td align="left"><p><bold> + ve</bold></p></td><td align="left" colspan="2"><p><bold>-ve</bold></p></td><td align="left" colspan="2"><p><bold>-ve</bold></p></td><td align="left" colspan="3"><p><bold> + ve</bold></p></td><td align="left"><p><bold> + ve</bold></p></td></tr></tbody></table></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>Phylogenetic tree of the partial sequence of 16S rRNA of the local isolate <italic>Streptomyces</italic> sp. NRCG4 respects to closely related sequences available in Gen Bank databases</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/43141_2023_530_Fig3_HTML.png" id="MO3"/></fig></p></sec><sec id="Sec27"><title>Isolation, partial purification, and chemical analysis of NRCG4</title><p id="Par45">EPS production was high (7.76 g/l) by <italic>Streptomyces</italic> sp. NRCG4. Ethanol precipitation and dehydration with acetone and diethyl ether were used to extract crude NRCG4 from fermented broth<italic>.</italic> The crude NRCG4 was subjected to another precipitation step with chilled absolute ethanol. The major fraction was obtained by three volumes of absolute ethanol which was dried under vacuum at 40 °C to generate NRCG4, which was employed in further analyses. It showed a negative Bradford test result without absorption in the UV spectrum at 280 nm or 260 nm, confirming the lack of protein and nucleic acid. It also included 16.0% uronic acid and 0.0% sulfate. A significant band at 3469.31 cm<sup>−1</sup> was seen in the FT-IR spectrum, which was attributed to carbohydrates O–H stretching vibration. C–H stretching vibration caused the 2444.33 cm<sup>−1</sup> band. The presence of COO<sup>−</sup> groups was revealed by a symmetrical extended peak about 1380.78 cm<sup>−1</sup> (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). C = O vibrations were blamed for the significant absorption at 1660.41 cm<sup>−1</sup>. Furthermore, distinctive absorptions at 859.32 cm<sup>−1</sup> suggest that α-configurations were present in NRCG4 at the same time [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>].<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>IR spectrum of NRCG4</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/43141_2023_530_Fig4_HTML.png" id="MO4"/></fig></p><p id="Par46">HPLC was used to examine the chemical structure of NRCG4 and compare it to monosaccharide standards. NRCG4 was made up of 1.2:1.5:2.8:1.0 molar ratios of mannuronic acid, glucose, mannose, and rhamnose. For the sections of peaks that lie within the peak ranges, the molecular weight of NRCG4 was computed. NRCG4 Mw was found to be 4.25 × 10<sup>5</sup> gmol<sup>−1</sup> and the Mn was found to be 1.97 × 10<sup>5</sup> gmol<sup>−1</sup>. The polydispersity index (Mw/Mn) is a metric for the molecular weight distribution’s width 2.1 (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). <italic>Streptomyces</italic> sp. is thus considered common host bacteria for industrial and medicinal applications.<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p>Molecular weight of NRCG4</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/43141_2023_530_Fig5_HTML.png" id="MO5"/></fig></p></sec><sec id="Sec28"><title>Neurotransmitter’s degradation inhibitory characters of NRCG4</title><sec id="Sec29"><title>Acetyl cholinesterase inhibitory action</title><p id="Par47">Acetylcholinesterase inhibitory property assessment has been used to determine the ability of exopolysaccharide to prevent neurotransmitter degradation that could provoke brain function in optimum. NRCG4 possessed significant and concentration-dependent AChE inhibitory action (Table <xref rid="Tab4" ref-type="table">4</xref>) as its inhibition percentage started with 33.72 ± 1.28% at 25 μg/ ml to 79.98 ± 2.50% at 400 μg/ ml. The calculated inhibitory action for 50% of enzyme activity value of NRCG4 was 87.29 μg/ ml.<table-wrap id="Tab4"><label>Table 4</label><caption xml:lang="en"><p>Acetylcholine esterase and butyrylcholinesterase inhibition activity of different concentrations (25–400 μg/ mL) of NRCG4</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"><p><bold>Concentrations (µg/ ml)</bold></p></th><th align="left" colspan="2"><p>NRCG4</p></th></tr><tr><th align="left"><p><bold>Acetylcholine esterase</bold></p></th><th align="left"><p><bold>Butyrylcholine esterase</bold></p></th></tr></thead><tbody><tr><td align="left"><p><bold>25</bold></p></td><td align="left"><p>33.72 ± 1.28</p></td><td align="left"><p>38.34 ± 0.66</p></td></tr><tr><td align="left"><p><bold>50</bold></p></td><td align="left"><p>46.34 ± 1.66</p></td><td align="left"><p>43.69 ± 1.67</p></td></tr><tr><td align="left"><p><bold>100</bold></p></td><td align="left"><p>55.81 ± 1.82</p></td><td align="left"><p>60.42 ± 1.58</p></td></tr><tr><td align="left"><p><bold>200</bold></p></td><td align="left"><p>63.85 ± 1.15</p></td><td align="left"><p>72.53 ± 1.59</p></td></tr><tr><td align="left"><p><bold>400</bold></p></td><td align="left"><p>79.98 ± 2.50</p></td><td align="left"><p>85.26 ± 1.74</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>87.29</bold></p></td><td align="left"><p><bold>71.38</bold></p></td></tr><tr><td align="left" colspan="3"><p><bold>Eserinhemisulphate IC</bold><sub><bold>50</bold></sub> was 0.03 µg/ml</p></td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec30"><title>Butyryl cholinesterase inhibitory action</title><p id="Par48">The inhibitory action of polysaccharide-6 on BChE was evaluated in in vitro assay and is summarized in Table <xref rid="Tab4" ref-type="table">4</xref>. NRCG4 polysaccharide exhibited potential inhibitory action on BChE and the inhibition was enhanced by increasing the concentration of NRCG4. Obtained results indicated that NRCG4 IC<sub>50</sub> value for butyrylcholinesterase was 71.38 μg/ ml.</p></sec><sec id="Sec31"><title>Anti-tyrosinase inhibitory activity</title><p id="Par49">L-tyrosine is used as the substrate in the determination of tyrosinase inhibitory activity of NRCG4. Data are presented in Table <xref rid="Tab5" ref-type="table">5</xref> as percentage of inhibition at gradual concentrations considering incubation time as well as IC<sub>50</sub> values in comparison with kojic acid, standard material. The inhibitory action of NRCG4 on tyrosinase was increased gradually with the increased consecutive concentrations and time-dependently. The greatest tested concn. (400 μg/ml) presented a promising tyrosinase inhibitory activity (98.59 ± 1.40%) after 40 min of incubation. In addition, kojic acid which was used as a positive control showed an inhibition level of 100% to tyrosinase at the same time and concentration with insignificant difference with tested polysaccharide. The minimum inhibitory action was produced with the minimum concentration (25 μg/ml) and it was increased time-dependently from 6.45% after 10 min of incubation to 45.13% after 20 min and continued its increasing to reach 71.23% after incubation for 40 min; the same trend of results was also obtained by the other concentrations. The second concentration (50 μg/ml) started the inhibition with 12.15% and elevated to 51.64% by increasing the time to 20 min and was maximized to 80.54% after 40 min of incubation. Accordingly, the suppressor action on tyrosinase was maximized from 21.64% for the third concentration (100 μg/ml) after 10 min to 67.95% after 20 min and elevated to 91.77% after 40 min of incubation. In parallel, tyrosinase was completely inhibited (98.59%) after 40 min of incubation time at 400 μg/ml whereas it started with 25.39% and magnified to 75.12% by duplication of incubation time to 20 min, insignificant differences were observed between kojic acid, reference material, at the two times (20 and 40 min), <italic>P</italic> ≤ <italic>0.05</italic>. The recorded IC<sub>50</sub> values at the two evaluated times (20 and 40 min) were 47.57 and 17.63 μg/ ml for NRCG4 and 99.62 and 18.07 μg/ml for kojic acid at the two evaluated times 20 and 40 min, respectively.<table-wrap id="Tab5"><label>Table 5</label><caption xml:lang="en"><p>Tyrosinase inhibition efficacy of different concentrations (25–400 μg/ mL) of NRCG4 in respect to kojic acid, reference material</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"><p>Concentrations (μg/ml)</p></th><th align="left" colspan="3"><p>NRCG4</p></th><th align="left" colspan="3"><p>Kojic acid</p></th></tr><tr><th align="left"><p><bold>10 min</bold></p></th><th align="left"><p><bold>20 min</bold></p></th><th align="left"><p><bold>40 min</bold></p></th><th align="left"><p><bold>10 min</bold></p></th><th align="left"><p><bold>20 min</bold></p></th><th align="left"><p><bold>40 min</bold></p></th></tr></thead><tbody><tr><td align="left"><p><bold>25</bold></p></td><td align="left"><p>6.45 ± 0.45<sup>a</sup></p></td><td align="left"><p>45.13 ± 0.87 <sup>a</sup></p></td><td align="left"><p>71.23 ± 1.77</p></td><td align="left"><p>9.34 ± 0.66</p></td><td align="left"><p>37.55 ± 1.45</p></td><td align="left"><p>70.32 ± 1.68</p></td></tr><tr><td align="left"><p><bold>50</bold></p></td><td align="left"><p>12.15 ± 0.85<sup>a</sup></p></td><td align="left"><p>51.64 ± 1.00 <sup>a</sup></p></td><td align="left"><p>80.54 ± 1.615</p></td><td align="left"><p>16.48 ± 0.52</p></td><td align="left"><p>43.11 ± 0.95</p></td><td align="left"><p>80.41 ± 1.59</p></td></tr><tr><td align="left"><p><bold>100</bold></p></td><td align="left"><p>18.37 ± 0.83<sup>a</sup></p></td><td align="left"><p>59.11 ± 1.41 <sup>a</sup></p></td><td align="left"><p>85.67 ± 2.67</p></td><td align="left"><p>25.88 ± 1.17</p></td><td align="left"><p>52.37 ± 1.63</p></td><td align="left"><p>85.75 ± 2.20</p></td></tr><tr><td align="left"><p><bold>200</bold></p></td><td align="left"><p>21.64 ± 0.69<sup>a</sup></p></td><td align="left"><p>67.95 ± 1.89 <sup>a</sup></p></td><td align="left"><p>91.77 ± 2.78</p></td><td align="left"><p>32.64 ± 0.68</p></td><td align="left"><p>61.84 ± 1.16</p></td><td align="left"><p>95.12 ± 1.33</p></td></tr><tr><td align="left"><p><bold>400</bold></p></td><td align="left"><p>25.39 ± 0.60<sup>a</sup></p></td><td align="left"><p>75.12 ± 2.88 <sup>a</sup></p></td><td align="left"><p>98.59 ± 1.40</p></td><td align="left"><p>40.35 ± 1.65</p></td><td align="left"><p>70.23 ± 1.77</p></td><td align="left"><p>100.0 ± 0.00</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>765.19</bold><sup><bold>a</bold></sup></p></td><td align="left"><p><bold>47.57 </bold><sup><bold>a</bold></sup></p></td><td align="left"><p><bold>17.63</bold></p></td><td align="left"><p><bold>566.00</bold></p></td><td align="left"><p><bold>99.62</bold></p></td><td align="left"><p><bold>18.07</bold></p></td></tr></tbody></table><table-wrap-foot><p>Data presented as mean ± SE. One-way ANOVA was used for data analysis (<italic>n</italic> = 3, <italic>P</italic> &lt; 0.05). Data are followed with small letter a means significant difference with kojic acid at the same time and concentration</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec32"><title>Anti-inflammatory property of NRCG4</title><p id="Par50">Anti-inflammatory efficacy of NRCG4 was evaluated as its inhibitory action on cyclooxygenases enzymes, COX-2 and COX-1, in respect to celecoxib as a reference drug. Celecoxib produced COX-1 inhibition percentage started with 44.12% ± 1.74 at 25 μg/ml and increased continuously to reach 81.61 ± 1.73% for 1000 μg/ ml whereas it was effective in inhibiting COX-2 as it recorded inhibition percentage ranged from 28.53 ± 1.02% at 5 μg/ ml to 81.61 ± 1.67% at 100 μg/ ml. On the contrary, data presented in Table <xref rid="Tab6" ref-type="table">6</xref> showed the selective inhibitory action of NRCG4 against COX-2. NRCG4 inhibited COX-2 in concentration-dependent manner (10.57 ± 1.00% at 5 μg/ ml till reaching 83.34 ± 1.34% at 100 μg/ml). It was evident from the obtained results that the inhibition of COX-2 by 50% required 28.91 μg/ml of NRCG4 which was greater than celecoxib (IC<sub>50</sub>; 27.45 ng/ ml). In parallel, NRCG4 exhibited a greater safety margin on physiological system as it showed greater IC<sub>50</sub> value for COX-1 (45.23 μg/ml) than reference drug (IC<sub>50;</sub> 40.61 μg/ml).<table-wrap id="Tab6"><label>Table 6</label><caption xml:lang="en"><p>COX-2 and COX-1 inhibition by different concentrations of NRCG4 and standard drug</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3"><p>COX-2</p></th><th align="left" colspan="3"><p>COX-1</p></th></tr><tr><th align="left" rowspan="3"><p><bold>Concentrations (µg/ml)</bold></p></th><th align="left" colspan="2"><p><bold>Inhibition percentage (%)</bold></p></th><th align="left" rowspan="3"><p><bold>Concentrations (µg/ ml)</bold></p></th><th align="left" rowspan="2" colspan="2"><p><bold>Inhibition percentage</bold></p></th></tr><tr><th align="left" rowspan="2"><p><bold>NRCG4</bold></p></th><th align="left" rowspan="2"><p><bold>Celecoxib</bold></p></th></tr><tr><th align="left"><p><bold>Polysaccharide</bold></p></th><th align="left"><p><bold>Celecoxib</bold></p></th></tr></thead><tbody><tr><td align="left"><p><bold>5</bold></p></td><td align="left"><p>10.57 ± 1.00<sup>a</sup></p></td><td align="left"><p>28.53 ± 1.02</p></td><td align="left"><p><bold>25</bold></p></td><td align="left"><p>46.71 ± 0.98</p></td><td align="left"><p>44.12 ± 1.74</p></td></tr><tr><td align="left"><p><bold>10</bold></p></td><td align="left"><p>30.37 ± 1.52<sup>a</sup></p></td><td align="left"><p>33.84 ± 1.31</p></td><td align="left"><p><bold>50</bold></p></td><td align="left"><p>57.48 ± 1.52</p></td><td align="left"><p>58.34 ± 1.38</p></td></tr><tr><td align="left"><p><bold>20</bold></p></td><td align="left"><p>42.15 ± 1.63<sup>a</sup></p></td><td align="left"><p>45.21 ± 0.99</p></td><td align="left"><p><bold>100</bold></p></td><td align="left"><p>66.71 ± 1.36</p></td><td align="left"><p>65.67 ± 1.06</p></td></tr><tr><td align="left"><p><bold>40</bold></p></td><td align="left"><p>68.99 ± 1.85<sup>a</sup></p></td><td align="left"><p>61.45 ± 2.07</p></td><td align="left"><p><bold>250</bold></p></td><td align="left"><p>72.19 ± 1.04</p></td><td align="left"><p>70 ± 1.08</p></td></tr><tr><td align="left"><p><bold>80</bold></p></td><td align="left"><p>77.62 ± 2.00<sup>a</sup></p></td><td align="left"><p>72.11 ± 1.48</p></td><td align="left"><p><bold>500</bold></p></td><td align="left"><p>75.44 ± 1.11</p></td><td align="left"><p>76.22 ± 0.96</p></td></tr><tr><td align="left"><p><bold>100</bold></p></td><td align="left"><p>83.34 ± 1.34</p></td><td align="left"><p>81.61 ± 1.67</p></td><td align="left"><p><bold>1000</bold></p></td><td align="left"><p>80.17 ± 1.42</p></td><td align="left"><p>81.61 ± 1.73</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>28.91</bold></p></td><td align="left"><p><bold>27.45</bold></p></td><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>45.23</bold></p></td><td align="left"><p><bold>50.61</bold></p></td></tr></tbody></table><table-wrap-foot><p>Data are presented as mean of three triplicates ± SE. One-way ANOVA was used for data analysis (<italic>n</italic> = 3, <italic>p</italic> &lt; <italic>0.05</italic>). Data are followed with small letter a which means significant difference with celecoxib at the same concentration</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec33"><title>Oxidative stress inhibitory characters</title><sec id="Sec34"><title>DPPH free radical scavenging ability</title><p id="Par51">The ability of NRCG4 to scavenge free radicals was assessed using the DPPH test in comparison to two standard components, ascorbic acid and BHT as shown in Table <xref rid="Tab7" ref-type="table">7</xref> (a). The presented results showed that NRCG4 appeared promising DPPH radical scavenging ability that was significantly increased when NRCG4 concentration was increased from 25 to 400 μg/ml (46.32 ± 1.68% and 88.26 ± 1.74%, respectively). On the other hand, BHT exhibited 80.46 ± 2.52% scavenging percentage increased to 98.32 ± 1.69% at the same two concentrations (<italic>P</italic> &lt; <italic>0.05</italic>). Considering IC<sub>50</sub> values, the scavenging ability of NRCG4 and standard materials against DPPH radical occurred in the following order Ascorbic acid &gt; BHT &gt; NRCG4 with significant differences (<italic>P</italic> &lt; <italic>0.05</italic>).<table-wrap id="Tab7"><label>Table 7</label><caption xml:lang="en"><p>Scavenging of DPPH, ABTS, SOR and NO ability, reduction capability, Fe <sup>2+</sup> ion chelation property, and lipid peroxidation inhibition of NRCG4 as compared with two reference standards ascorbic acid and BHT</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Concentration (μg/mL)</p></th><th align="left"><p>NRCG4</p></th><th align="left"><p>Ascorbic acid</p></th><th align="left"><p>BHT</p></th></tr></thead><tbody><tr><td align="left" colspan="4"><p>a. <bold>DPPH</bold></p></td></tr><tr><td align="left"><p> 25</p></td><td align="left"><p>46.32<sup>b</sup> ± 1.68</p></td><td align="left"><p>75.17 ± 1.30</p></td><td align="left"><p>80.46 ± 2.52</p></td></tr><tr><td align="left"><p> 50</p></td><td align="left"><p>79.08<sup>ab</sup> ± 3</p></td><td align="left"><p>90.31 ± 2.31</p></td><td align="left"><p>96.10 ± 2.90</p></td></tr><tr><td align="left"><p> 100</p></td><td align="left"><p>81.46<sup>ab</sup> ± 2.48</p></td><td align="left"><p>95.28 ± 3.20</p></td><td align="left"><p>97.88 ± 2.11</p></td></tr><tr><td align="left"><p> 200</p></td><td align="left"><p>84.88<sup>ab</sup> ± 2.12</p></td><td align="left"><p>97.50 ± 2.00</p></td><td align="left"><p>98.00 ± 2.00</p></td></tr><tr><td align="left"><p> 400</p></td><td align="left"><p>88.26<sup>ab</sup> ± 1.74</p></td><td align="left"><p>100.00 ± 0.00</p></td><td align="left"><p>98.32 ± 1.69</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>40.12</bold></p></td><td align="left"><p><bold>31.34</bold></p></td><td align="left"><p><bold>28.18</bold></p></td></tr><tr><td align="left" colspan="4"><p><bold>b. ABTS</bold></p></td></tr><tr><td align="left"><p> 25</p></td><td align="left"><p>47.94 ± 0.56<sup>ab</sup></p></td><td align="left"><p>66.32 ± 2.68</p></td><td align="left"><p>62.18 ± 1.81</p></td></tr><tr><td align="left"><p> 50</p></td><td align="left"><p>61.11 ± 1.56 <sup>ab</sup></p></td><td align="left"><p>81.94 ± 1.06</p></td><td align="left"><p>83.31 ± 1.69</p></td></tr><tr><td align="left"><p> 100</p></td><td align="left"><p>76.55 ± 1.90 <sup>ab</sup></p></td><td align="left"><p>90.89 ± 1.90</p></td><td align="left"><p>90.01 ± 1.50</p></td></tr><tr><td align="left"><p> 200</p></td><td align="left"><p>89.69 ± 1.73 <sup>ab</sup></p></td><td align="left"><p>95.25 ± 2.25</p></td><td align="left"><p>94.00 ± 1.75</p></td></tr><tr><td align="left"><p> 400</p></td><td align="left"><p>98.69 ± 0.51</p></td><td align="left"><p>100.00 ± 0.0</p></td><td align="left"><p>100.00 ± 0.0</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>31.91 </bold><sup><bold>ab</bold></sup></p></td><td align="left"><p><bold>18.61</bold></p></td><td align="left"><p><bold>23.44</bold></p></td></tr><tr><td align="left" colspan="4"><p><bold>c. Reduction capability</bold></p></td></tr><tr><td align="left"><p> 25</p></td><td align="left"><p>0.166 ± 0.04 <sup>ab</sup></p></td><td align="left"><p>0.392 ± 0.004</p></td><td align="left"><p>0.287 ± 0.013</p></td></tr><tr><td align="left"><p> 50</p></td><td align="left"><p>0.210 ± 0.03 <sup>ab</sup></p></td><td align="left"><p>0.583 ± 0.013</p></td><td align="left"><p>0.492 ± 0.05</p></td></tr><tr><td align="left"><p> 100</p></td><td align="left"><p>0.352 ± 0.03 <sup>ab</sup></p></td><td align="left"><p>0.64 ± 0.04</p></td><td align="left"><p>0.534 ± 0.01</p></td></tr><tr><td align="left"><p> 200</p></td><td align="left"><p>0.450 ± 0.03 <sup>ab</sup></p></td><td align="left"><p>0.722 ± 0.05</p></td><td align="left"><p>0.588 ± 0.02</p></td></tr><tr><td align="left"><p> 400</p></td><td align="left"><p>0.558 ± 0.02 <sup>ab</sup></p></td><td align="left"><p>0.780 ± 0.003</p></td><td align="left"><p>0.603 ± 0.03</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>150.34 </bold><sup><bold>ab</bold></sup></p></td><td align="left"><p><bold>85.17</bold></p></td><td align="left"><p><bold>88.11</bold></p></td></tr><tr><td align="left" colspan="4"><p><bold>d. Fe 2 + ion chelation ability</bold></p></td></tr><tr><td align="left"><p> 25</p></td><td align="left"><p>35.43 ± 1.57<sup>ab</sup></p></td><td align="left"><p>62.99 ± 1.01</p></td><td align="left"><p>52.41 ± 1.59</p></td></tr><tr><td align="left"><p> 50</p></td><td align="left"><p>39.21 ± 2.00<sup>ab</sup></p></td><td align="left"><p>82.33 ± 1.67</p></td><td align="left"><p>87.93 ± 2.00</p></td></tr><tr><td align="left"><p> 100</p></td><td align="left"><p>43.76 ± 1.78<sup>ab</sup></p></td><td align="left"><p>91.50 ± 2.52</p></td><td align="left"><p>94.16 ± 2.11</p></td></tr><tr><td align="left"><p> 200</p></td><td align="left"><p>46.10 ± 1.90<sup>ab</sup></p></td><td align="left"><p>94.75 ± 1.95</p></td><td align="left"><p>97.50 ± 2.05</p></td></tr><tr><td align="left"><p> 400</p></td><td align="left"><p>47.95 ± 1.96<sup>ab</sup></p></td><td align="left"><p>98.19 ± 1.82</p></td><td align="left"><p>99.09 ± 0.90</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>416.38</bold><sup><bold>ab</bold></sup></p></td><td align="left"><p><bold>16.36</bold></p></td><td align="left"><p><bold>18.87</bold></p></td></tr><tr><td align="left" colspan="4"><p><bold>e. Lipid peroxidation Inhibition capacity</bold></p></td></tr><tr><td align="left"><p> 25</p></td><td align="left"><p>39.48 ± 0.52<sup>ab</sup></p></td><td align="left"><p>64.73 ± 2.20</p></td><td align="left"><p>60.31 ± 1.69</p></td></tr><tr><td align="left"><p> 50</p></td><td align="left"><p>43.69 ± 0.79 <sup>ab</sup></p></td><td align="left"><p>74.58 ± 3.00</p></td><td align="left"><p>76.41 ± 0.59</p></td></tr><tr><td align="left"><p> 100</p></td><td align="left"><p>48.77 ± 1.78 <sup>ab</sup></p></td><td align="left"><p>88.74 ± 3.20</p></td><td align="left"><p>87.51 ± 1.60</p></td></tr><tr><td align="left"><p> 200</p></td><td align="left"><p>51.37 ± 0.63 <sup>ab</sup></p></td><td align="left"><p>94.37 ± 2.75</p></td><td align="left"><p>93.75 ± 1.75</p></td></tr><tr><td align="left"><p> 400</p></td><td align="left"><p>53.44 ± 1.78 <sup>ab</sup></p></td><td align="left"><p>100.00 ± 0.00</p></td><td align="left"><p>100.00 ± 0.00</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>190.45 </bold><sup><bold>ab</bold></sup></p></td><td align="left"><p><bold>18.33</bold></p></td><td align="left"><p><bold>19.65</bold></p></td></tr><tr><td align="left" colspan="4"><p><bold>f. O</bold><sup><bold>2−</bold></sup><bold> radicals scavenging capacity</bold></p></td></tr><tr><td align="left"><p> 25</p></td><td align="left"><p>65.91b ± 2.09</p></td><td align="left"><p>66.21 ± 1.79</p></td><td align="left"><p>73.22 ± 2.78</p></td></tr><tr><td align="left"><p> 50</p></td><td align="left"><p>73.13ab ± 1.87</p></td><td align="left"><p>80.37 ± 2.30</p></td><td align="left"><p>83.61 ± 3.36</p></td></tr><tr><td align="left"><p> 100</p></td><td align="left"><p>74.73ab ± 3.03</p></td><td align="left"><p>95.34 ± 2.66</p></td><td align="left"><p>97.21 ± 2.79</p></td></tr><tr><td align="left"><p> 200</p></td><td align="left"><p>79.02ab ± 1.98</p></td><td align="left"><p>97.25 ± 1.75</p></td><td align="left"><p>97.88 ± 1.55</p></td></tr><tr><td align="left"><p> 400</p></td><td align="left"><p>81.27ab ± 2.73</p></td><td align="left"><p>97.75 ± 2.25</p></td><td align="left"><p>98.11 ± 1.89</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>14.22 </bold><sup><bold>ab</bold></sup></p></td><td align="left"><p><bold>12.35</bold></p></td><td align="left"><p><bold>11.01</bold></p></td></tr><tr><td align="left" colspan="4"><p><bold>g. NO scavenging capacity</bold></p></td></tr><tr><td align="left"><p> 25</p></td><td align="left"><p>17.89 ± 0.90 <sup>ab</sup></p></td><td align="left"><p>64.39 ± 1.61</p></td><td align="left"><p>65.99 ± 2.00</p></td></tr><tr><td align="left"><p> 50</p></td><td align="left"><p>25.87 ± 0.90 <sup>ab</sup></p></td><td align="left"><p>78.68 ± 1.70</p></td><td align="left"><p>77.92 ± 2.00</p></td></tr><tr><td align="left"><p> 100</p></td><td align="left"><p>39.20 ± 1.27 <sup>ab</sup></p></td><td align="left"><p>86.15 ± 1.95</p></td><td align="left"><p>88.72 ± 2.00</p></td></tr><tr><td align="left"><p> 200</p></td><td align="left"><p>45.59 ± 1.13 <sup>ab</sup></p></td><td align="left"><p>90.25 ± 2.00</p></td><td align="left"><p>91.75 ± 1.55</p></td></tr><tr><td align="left"><p> 400</p></td><td align="left"><p>58.64 ± 1.20 <sup>ab</sup></p></td><td align="left"><p>93.27 ± 2.73</p></td><td align="left"><p>95.88 ± 1.89</p></td></tr><tr><td align="left"><p><bold>IC</bold><sub><bold>50</bold></sub></p></td><td align="left"><p><bold>322.96 </bold><sup><bold>ab</bold></sup></p></td><td align="left"><p><bold>19.96</bold></p></td><td align="left"><p><bold>18.93</bold></p></td></tr></tbody></table><table-wrap-foot><p><italic>BHT</italic>, butylated hydroxy toluene. Data are presented as mean ± SE. One-way ANOVA was used for data analysis (<italic>n</italic> = 3, <italic>P</italic> &lt; <italic>0.05</italic>). Data are followed with small letter a means significant difference with ascorbic Acid and b means significant difference with BHT</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec35"><title>ABTS cation radicals scavenging capability</title><p id="Par52">The ABTS/ H<sub>2</sub>O<sub>2</sub> discoloration method was used to test the ability of NRCG4 and reference materials to scavenge ABTS radicals at different concentrations (Table <xref rid="Tab7" ref-type="table">7</xref> (b)). NRCG4 displayed powerful scavenging ABTS<sup>+</sup> cation radical character as compared to two reference materials, as evidenced by a discolored bluish-green complex of ABTS/H<sub>2</sub>O<sub>2</sub> that increased concentration-dependently. NRCG4 showed high activity at the lowest concentration 25 μg/ml, (47.94 ± 0.56%) which increased gradually to 98.69 ± 0.51% by increasing concentration to 400 μg/ ml, with respect to vitamin C (66.32 ± 2.68% and 100 ± 0.00% for the same concentrations, respectively) and BHT (62.18 ± 1.81% and 100 ± 0.01%, respectively) (<italic>P</italic> &lt; <italic>0.05</italic>). The IC<sub>50</sub> of NRCG4 in ABTS + system was 31.91 μg/ml, whereas BHT and ascorbic acid exerted 23.44 μg/ml and 18.61 μg/ml, respectively.</p></sec><sec id="Sec36"><title>Reduction capability</title><p id="Par53">The Fe<sup>3+</sup> reductive capability of NRCG4 was assessed using Fe<sup>3+</sup>-Fe<sup>2+</sup> transformation test and was compared to ascorbic acid and BHT as reference materials. Ferric ions were reduced to ferrous ions in potassium ferricyanide method when more electrons are donated by antioxidant components. Table <xref rid="Tab7" ref-type="table">7</xref> (c) clears that, as a reducing agent, NRCG4 had a limited effect with significant changes as concentration was changed. Furthermore, reduction ability of NRCG4 was increased significantly with increasing concentrations. NRCG4 exhibited reductive ability (absorbance; 0.558 ± 0.02) and it remained lower than vitamin C (0.780 ± 0.003) and BHT (0.603 ± 0.03). Regarding efficacy arrangement, NRCG4 and standard materials reduction ability were ordered as follows; NRCG4 &lt; BHT &lt; vitamin C (<italic>P</italic> &lt; <italic>0.05</italic>).</p></sec><sec id="Sec37"><title><bold><italic>Fe </italic></bold><sup><bold><italic>2</italic></bold>+</sup><bold><italic>ion chelation ability</italic></bold></title><p id="Par54">For testing NRCG4 and standard materials (vitamin C and BHT) chelating efficacy, ferrous ion (Fe<sup>+</sup>) chelation was evaluated among the transition metals by generating complexes with ferrozine, and the obtained data were presented in Table <xref rid="Tab7" ref-type="table">7</xref> (d). NRCG4 appeared to have a moderate ability to chelate ferrous ions in respect to ascorbic acid and BHT. NRCG4 inhibited the formation of Fe<sup>2+</sup>-ferrozine complex which means they are able to capture ferrous ion before ferrozine and prevented complex formation. NRCG4 recorded 35.43 ± 1.57 chelating percentage at minimum concentration and it was increased to 47.95 ± 1.96% with the highest one, in respect to vitamin C (62.99 ± 1.01% and 98.19 ± 1.82%, respectively) and BHT (52.41 ± 1.59% and 99.09 ± 0.90%, respectively) at the same concentrations (<italic>P</italic> &lt; <italic>0.05</italic>). Values of IC<sub>50</sub> for NRCG4, BHT, and vitamin C were as follows: 416.38, 18.87, and 16.36 μg/ ml, respectively.</p></sec><sec id="Sec38"><title>Lipid peroxidation Inhibition capacity</title><p id="Par55">The capacity of NRCG4 to reduce lipid peroxidation was assessed using the thiocyanate technique. Linoleate radicals oxidized ferrous ion to hydroperoxides to generate ferric ion, which was then measured spectrophotometrically as a thiocyanate complex at 500 nm in the thiocyanate system. In the emulsion, NRCG4 revealed a preventive effect of linoleic acid against peroxidation (Table <xref rid="Tab7" ref-type="table">7</xref> (e)). NRCG4 inhibited linoleic acid peroxidation in a concentration-dependent manner; the lowest linoleic acid peroxidation inhibition activity (39.48 ± 0.52%) was reported with the lowest concentration (25 μg/ ml). In comparison to ascorbic acid, the greatest percentage)53.44 ± 1.78%) was provided with the maximum concentration (400 μg/ ml) (64.73 ± 2.20% and 100.00 ± 0.00 for the two concns., respectively) and BHT (60.31 ± 1.69% and 100.00 ± 0.00%, respectively). To prevent 50% of linoleic acid oxidation into peroxide, 190.45 μg/ml of NRCG4 was required whereas BHT at 19.65 μg/ml and ascorbic acid at 18.33 μg ml are required for the same effect.</p></sec><sec id="Sec39"><title><bold><italic>O</italic></bold><sub><bold><italic>2</italic></bold></sub><bold><italic> radicals scavenging capacity</italic></bold></title><p id="Par56">NBT (yellow dye NBT<sup>2+</sup>) is reduced by superoxide anion (SOR) radicals formed in the PMS–NADH–NBT system by dissolving oxygen in the PMS–NADH coupling reaction. (Table <xref rid="Tab7" ref-type="table">7</xref> (f)) shows the proportion of generated SOR that was inhibited by NRCG4 at gradual concentrations when compared to reference materials at the same concentrations. NRCG4 exhibited SOR scavenging percentage ranged from 65.91 ± 2.09% at 25 μg/ml to 81.27 ± 2.73% at 400 μg/ml, with respect to those of ascorbic acid (66.21 ± 1.7% and 97.75 ± 2.25%, respectively) and BHT (73.22 ± 2.78% and 98.11 ± 1.89%, respectively). NRCG4 exhibited low IC<sub>50</sub> value (14.67 μg/ ml) while BHT and ascorbic acid presented 11.01 μg/ml and 12.35 μg/ml, respectively, with significant differences among them (<italic>P</italic> &lt; <italic>0.05</italic>).</p></sec><sec id="Sec40"><title>NO scavenging capacity</title><p id="Par57">NO radical scavenging ability of NRCG4 was estimated by a SNP generating NO system. NO released from SNP in aqueous solution at physiological pH reacts with oxygen to generate nitrite ions which were measured. In the data presented in Table (7 (g)), NRCG4 occurred a significant decrease in nitrite liberated in SNP assay medium represented as moderate NO scavenging action compared to references materials. The NO scavenging capacity was concentration dependent. Therefore, the NO scavenging action of NRCG4 significantly rose from 17.89 ± 0.90% at 25 μg/ml to 58.64 ± 1.20% at the highest concentration (400 μg/ ml) which were lower than ascorbic acid (64.39 ± 1.61% and 93.27 ± 2.73% at the same concns, respectively) and BHT (65.99 ± 2.00% and 5.88 ± 3.56%, respectively, at the same two concentrations). The amount of NRCG4 to capture 50% of generated NO was 322.96 μg/ ml which was higher than those of both BHT (18.93 μg/ ml) and ascorbic acid (19.96 μg/ ml).</p></sec></sec><sec id="Sec41" sec-type="discussion"><title>Discussion</title><p id="Par58">One of the primary factors contributing to an increase in neuronal disease (ND) instances around the world is the increase in modern man’s life expectancy, as well as the complexity of NDs and the lack of an acceptable NDs cure [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Given the rise in the senior population, NDs will continue to be vital for scientists to effectively address [<xref ref-type="bibr" rid="CR48">48</xref>]. In general, NDs cause cognitive and memory impairment, which impairs a person’s ability to breathe, move, and communicate. As a result, given the distress that NDs cause, effective treatments are required to improve patients’ quality of life [<xref ref-type="bibr" rid="CR46">46</xref>].</p><p id="Par59">The goal of this research was to find a new natural substance that may be used to treat Alzheimer’s disease to obviate the side effects of synthetic drugs. As a result of their unique living conditions, marine microorganisms frequently create bioactive compounds with novel activities and structures [<xref ref-type="bibr" rid="CR49">49</xref>]. New medications rely on EPSs from marine microbes [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. So, totally, ten isolates from the Red Sea, Hurghada, Egypt, were screened for the production of EPSs. Two isolates only could highly produce polysaccharide (NRCG1 and NRCG4). The most active isolate that has high acetyl cholinesterase inhibition activity (NRCG4) was subjected to morphological, physiological, and biochemical characteristics and by 16 s rRNA. Therefore, it was identified as <italic>Streptomyces</italic> sp. NRCG4 with accession number MK850242<bold>.</bold></p><p id="Par60">Our study demonstrated that NRCG4 could treat Alzheimer’s risk factors via inhibition of cholinesterase and tyrosinase as well as anti-inflammatory and antioxidant abilities. NRCG4 occurred a potential role in the suppression of Alzheimer’s disease biomarkers through its antioxidant (metal chelation, ROS scavenging, and radical activities) and anti-inflammatory characteristics of NRCG4 that assigned to its unique chemical composition.</p><p id="Par61">Existing treatments for Alzheimer’s are expensive and come with several negative side effects [<xref ref-type="bibr" rid="CR52">52</xref>]. Given that existing medicines can only treat the symptoms of NDs and that the disease is linked to aging, there is a pressing need to discover medications that can slow the progression of the disease [<xref ref-type="bibr" rid="CR53">53</xref>].</p><p id="Par62">L-DOPA, commonly known as Levodopa and L-3, 4-dihydroxyphenylalanine, is well known for its use as a treatment for vascular dementia. L-DOPA is the precursor for the neurotransmitter dopamine and is produced by the action of the enzyme tyrosinase on the amino acid tyrosine. In Alzheimer’s disease, aggregation of the peptide droves to the development of amyloid plaque formation followed by neurodegenerative changes. L-DOPA and dopamine can dissolve fibrils of a peptide and can inhibit the formation of protein tangles [<xref ref-type="bibr" rid="CR54">54</xref>]. Unfortunately, tyrosinase can oxidize dopamine’s catechol ring to the extremely reactive dopamine-quinone. Dopamine transporter is inhibited by dopamine oxidation too, glutamate transport, and mitochondrial respiration. Thus, inhibition of tyrosinase can control and treat Alzheimer’s disease [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. One of the factors that contribute to the development of Alzheimer’s disease is the aggregation of Aβ protein. On the other hand the importance of non-steroidal anti-inflammatory medications (NSAIDs) as aggregation inhibitors has been demonstrated by numerous studies [<xref ref-type="bibr" rid="CR57">57</xref>]. NSAIDs have even been shown in lab trials to reduce AD pathogenesis by inhibiting microglial activation or Aβ peptide deposition. [<xref ref-type="bibr" rid="CR58">58</xref>–<xref ref-type="bibr" rid="CR60">60</xref>].</p><p id="Par63">Hasegawa et al. [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>] chose catecholaminergic neuronal cell lines that express tyrosinase in response to an external inducer such as doxycycline. In these cell lines, overexpression of the tyrosinase protein resulted in an increase in intracellular dopamine and reactive oxygen species (ROS), as well as the development of melanin pigments in neuronal somata, which leads to apoptotic cell death. Juneja et al. [<xref ref-type="bibr" rid="CR63">63</xref>] used blastula protease-10 peptide as a tyrosinase-like mimic to study Type III-Copper proteins like tyrosinase’s intermediates and mechanisms. Furthermore, H<sub>2</sub>O<sub>2</sub> activated the model and served as the second substrate in a bi-substrate reaction. Tyrosinase is a copper-containing enzyme that catalyzes the conversion of oxidized tyrosine to dopa and dopaquinone. Because of the copper structure in tyrosinase, various studies have looked into the potential function of metal-chelating substances such as kojic acid, catechol, gentisic acid, flavonol, and hydroxamic acid in tyrosinase activity management [<xref ref-type="bibr" rid="CR64">64</xref>]. Generally, flavonoids with a hydroxyl group at A and B rings are very important tyrosinase inhibitors by Cu<sup>2+</sup> chelation [<xref ref-type="bibr" rid="CR65">65</xref>]. Polysaccharide NRCG4 represented chelating efficacy that was increased dependently by increasing concentration which could be one of its mechanisms to face Alzheimer progression or its treatment.</p><p id="Par64">Many studies have focused on phenolic compounds in particular because of their antioxidant properties, which could be linked to neuroprotective properties by decreasing endogenous ROS generation, restoring mitochondrial membrane potential, enhancing superoxide dismutase activity, and elevating intracellular Ca<sup>2+</sup> levels [<xref ref-type="bibr" rid="CR66">66</xref>]. Taking this hypothesis into consideration, the antioxidant properties of examined polysaccharide NRCG4 could participate in the neuronal protection of cells from death and consequently save brain maintenance and treating Alzheimer’s signs.</p><p id="Par65">A decrease in the neurotransmitter acetylcholine (Ach) is thought to be a key factor in the development of dementia in Alzheimer’s disease patients. As a result, people with Alzheimer’s disease must suppress both major forms of cholinesterase, AChE and BChE, in order to restore acetylcholine levels. In Alzheimer’s disease, inhibition of AChE plays a crucial role in increasing cholinergic transmission in the brain and lowering amyloid beta peptide (Aβ) aggregation and the generation of neurotoxic fibrils [<xref ref-type="bibr" rid="CR35">35</xref>]. AChE protein consists of 531 amino acid residues with an ellipsoid shape. AChE has two binding sites; the first is involved in the interaction of positively charged function group as nitrogen in alkaloid derivatives, and the second can interact with other non-alkaloid components as phenols [<xref ref-type="bibr" rid="CR67">67</xref>]. The considered NRCG4 in this study was characterized to have 16% uronic acid and the mannuronic acid was constituted at 1.2 molar ratio which may accept the negative charge for molecule that may interact with the other side of acetylcholinesterase causing enzyme block showed in enzyme inhibitory action.</p><p id="Par66">Materials that have antioxidant activity and acetylcholinesterase inhibitory action are considered promising in treating Alzheimer’s disease. For example, <italic>Centella asiatica</italic> (L.) Urb. is a valuable medicinal plant used to cure cognitive ailments and mental health issues, according to studies. A recent study found that an ethanolic extract of <italic>C. asiatica</italic> significantly reduces oxidative stress and AChE activity in the brain produced by D-gal, while also preserving normal cellular architecture in the hippocampus and cortical areas. The study’s authors found that <italic>C. asiatica</italic> can protect the brain from D-negative gal’s consequences, such as memory loss [<xref ref-type="bibr" rid="CR68">68</xref>]. In our presented study, NRCG4 contains many sugars like galactose, L-arabinose which may be the cause of higher selectivity to AChE than BuChE.</p><p id="Par67"><italic>Streptomyces</italic> sp. is considered common host bacteria for industrial and medicinal applications. Furthermore, some <italic>Streptomyces</italic> produce EPSs with biological functions [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. The majority of marine bacteria created heteropolysaccharides, which are polysaccharides made up of different monosaccharides. Additionally, it has been discovered that glucose and mannose have receptors on macrophages that are unique for tumor immunology [<xref ref-type="bibr" rid="CR71">71</xref>]. The results of molecular weight are similar to those of Sutherland [<xref ref-type="bibr" rid="CR72">72</xref>], who noted that a major fraction of EPSs given from marine sources have an average molecular weight of 1–3 × 10<sup>5</sup> Da. The molecular weight and biological activity of EPSs are related; the activity is dependent on the number of molecules as well as the degree of branching and conformation [<xref ref-type="bibr" rid="CR73">73</xref>].</p><p id="Par68">It is believed that Alzheimer risk factors including environmental, biological, and genetic factors associated with elevating level of inflammatory biomarkers that can promote advanced cognitive deterioration. In addition, it was demonstrated that the development of different central nervous system (CNS) diseases, e.g., Alzheimer’s disease, is related to neuroinflammation. Inflammatory process development implicates a widely spread range of molecular interactions which represent important CNS changes outcomes. These changes contribute to CNS regulation and function impairment that increased the level of inflammatory marker [<xref ref-type="bibr" rid="CR74">74</xref>]. When the inflammatory cascade was initiated the neuroinflammatory process becomes highly activated to make further cellular damage to loss their function which is accompanied with neurofibrillary tangles and amyloid plaques formation, Alzheimer’s hallmarks [<xref ref-type="bibr" rid="CR75">75</xref>]. Therefore, the anti-inflammatory effect of NRCG4 was determined. The investigated polysaccharide exerted selective inhibitory action against COX-2 which led to decreasing the production of inflammatory cytokines in cells that is recommended as targeted mechanism in treating Alzheimer’s disease and this selectivity could keep brain and body maintenance.</p></sec><sec id="Sec42" sec-type="conclusions"><title>Conclusion</title><p id="Par69">In the current study, the exopolysaccharide was produced from <italic>Streptomyces</italic> sp. NRCG4 which isolated from marine sample of the Red Sea, Hurghada, Egypt. NRCG4 exhibited promising antioxidant characteristics (metal chelation, ROS scavenging, radical scavenging capability, and inhibition of lipid peroxide production) and selective inhibitory effects against COX-2, referring that it could be a promising natural raw material to treat inflammation-related diseases as Alzheimer’s. Additionally, it possessed tyrosinase inhibitory action and neurotransmitters degradation inhibitory action that supports its role as pronounced Alzheimer’s treating agent. The promising therapeutic features of NRCG4 may attribute to its structure and features.</p></sec></body><back><ack><title>Acknowledgements</title><p>This presented study was financially supported by National Research Centre, Egypt, through Project No. 11010319 entitled “Natural Product for Treating Alzheimer's disease; Alternative approach”.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>This study was supported by National Research Centre.</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this article.</p></sec><sec sec-type="ethics-statement"><title>Declarations</title><sec id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par70">Not applicable.</p></sec><sec id="FPar3"><title>Consent for publication</title><p id="Par71">Not applicable.</p></sec><sec id="FPar4" sec-type="COI-statement"><title>Competing interests</title><p id="Par72">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>AK</given-names></name><name><surname>Michaud</surname><given-names>P</given-names></name><name><surname>Singhania</surname><given-names>RR</given-names></name><name><surname>Soccol</surname><given-names>CR</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Polysaccharides from probiotics: new developments as food additives</article-title><source>Food Technology and Biotechnology</source><year>2010</year><volume>48</volume><fpage>451</fpage><lpage>463</lpage></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelhamid</surname><given-names>SA</given-names></name><name><surname>Mohamed</surname><given-names>SS</given-names></name><name><surname>Selim</surname><given-names>MS</given-names></name></person-group><article-title xml:lang="en">Medical application of exopolymers produced by marine bacteria</article-title><source>Bulletin of the National Research Centre</source><year>2020</year><volume>44</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/s42269-020-00323-x</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>AY</given-names></name><name><surname>Mahmoud</surname><given-names>M</given-names></name><name><surname>Asker</surname><given-names>MM</given-names></name></person-group><article-title xml:lang="en">Anti-inflammatory and antioxidant activities of polysaccharide from Adansonia digitata: An in vitro study</article-title><source>Int J Pharm Sci Rev Res</source><year>2014</year><volume>25</volume><fpage>174</fpage><lpage>182</lpage></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Asker, M.M., Ibrahim, A.Y., Mahmoud, M.G., and Mohamed, S.S. (2015). Production and characterization of exopolysaccharide from novel Bacillus sp. M3 and evaluation on development sub-chronic aluminum toxicity induced Alzheimer's disease in male rats. American Journal of Biochemistry &amp; Biotechnology <italic>11</italic>, 92.</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Mahmoud, M.G., Ibrahim, A.Y., Asker, M.M., and El Sayed, O.H. (2014). Therapeutic potential and structural elucidation of a water-soluble polysaccharide of a wild edible mushroom Agaricus bisporus against neurodegenerative disease, Alzheimer. World Journal of Pharmaceutical Sciences, 1136–1145.</mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Omura</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Agroactive compounds of microbial origin</article-title><source>Annu Rev Microbiol</source><year>1993</year><volume>47</volume><fpage>57</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1146/annurev.mi.47.100193.000421</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selim</surname><given-names>MSM</given-names></name><name><surname>Abdelhamid</surname><given-names>SA</given-names></name><name><surname>Mohamed</surname><given-names>SS</given-names></name></person-group><article-title xml:lang="en">Secondary metabolites and biodiversity of actinomycetes</article-title><source>Journal of Genetic Engineering and Biotechnology</source><year>2021</year><volume>19</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1186/s43141-021-00156-9</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>MG</given-names></name><name><surname>Selim</surname><given-names>MS</given-names></name><name><surname>Mohamed</surname><given-names>SS</given-names></name><name><surname>Hassan</surname><given-names>AI</given-names></name><name><surname>Abdal-Aziz</surname><given-names>SA</given-names></name></person-group><article-title xml:lang="en">Study of the chemical structure of exopolysaccharide produced from streptomycete and its effect as an attenuate for antineoplastic drug 5-fluorouracil that induced gastrointestinal toxicity in rats</article-title><source>Anim Biotechnol</source><year>2020</year><volume>31</volume><fpage>397</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1080/10495398.2019.1610416</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>HM</given-names></name><name><surname>Abdel-Rahman</surname><given-names>RF</given-names></name><name><surname>El Awdan</surname><given-names>SA</given-names></name><name><surname>Allam</surname><given-names>RM</given-names></name><name><surname>El-Mosallamy</surname><given-names>AE</given-names></name><name><surname>Selim</surname><given-names>MS</given-names></name><name><surname>Mohamed</surname><given-names>SS</given-names></name><name><surname>Arbid</surname><given-names>MS</given-names></name><name><surname>Farrag</surname><given-names>ARH</given-names></name></person-group><article-title xml:lang="en">Protective effect of some natural products against chemotherapy-induced toxicity in rats</article-title><source>Heliyon</source><year>2019</year><volume>5</volume><pub-id pub-id-type="doi">10.1016/j.heliyon.2019.e01590</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeke</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">LIFESTYLE CORNER; Take a Walk: Prevent Alzheimer's Disease</article-title><source>National Women's Health Report</source><year>2004</year><volume>26</volume><fpage>8</fpage></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De la Monte</surname><given-names>SM</given-names></name><name><surname>Wands</surname><given-names>JR</given-names></name></person-group><article-title xml:lang="en">Alzheimer's disease is type 3 diabetes—evidence reviewed</article-title><source>J Diabetes Sci Technol</source><year>2008</year><volume>2</volume><fpage>1101</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1177/193229680800200619</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayakawa</surname><given-names>M</given-names></name><name><surname>Nonomura</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Humic acid-vitamin agar, a new medium for the selective isolation of soil actinomycetes</article-title><source>J Ferment Technol</source><year>1987</year><volume>65</volume><fpage>501</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1016/0385-6380(87)90108-7</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Waksman, S.A. (1961). The Actinomycetes. Vol. II. Classification, identification and descriptions of genera and species. The Actinomycetes. Vol. II. Classification, identification and descriptions of genera and species.</mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusconi</surname><given-names>R</given-names></name><name><surname>Godinho</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Screening for exopolysaccharide-producing bacteria from sub-tropical polluted groundwater</article-title><source>Braz J Biol</source><year>2002</year><volume>62</volume><fpage>363</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1590/S1519-69842002000200020</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manivasagan</surname><given-names>P</given-names></name><name><surname>Sivasankar</surname><given-names>P</given-names></name><name><surname>Venkatesan</surname><given-names>J</given-names></name><name><surname>Senthilkumar</surname><given-names>K</given-names></name><name><surname>Sivakumar</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>S-K</given-names></name></person-group><article-title xml:lang="en">Production and characterization of an extracellular polysaccharide from Streptomyces violaceus MM72</article-title><source>Int J Biol Macromol</source><year>2013</year><volume>59</volume><fpage>29</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2013.04.012</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Xiao</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Isolation, structural characterization and immunological activity of an exopolysaccharide produced by Bacillus licheniformis 8–37-0-1</article-title><source>Biores Technol</source><year>2010</year><volume>101</volume><fpage>5528</fpage><lpage>5533</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2010.01.151</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shene</surname><given-names>C</given-names></name><name><surname>Canquil</surname><given-names>N</given-names></name><name><surname>Bravo</surname><given-names>S</given-names></name><name><surname>Rubilar</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Production of the exopolysacchzrides by Streptococcus thermophilus: Effect of growth conditions on fermentation kinetics and intrinsic viscosity</article-title><source>Int J Food Microbiol</source><year>2008</year><volume>124</volume><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2008.03.013</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tresner</surname><given-names>H</given-names></name><name><surname>Backus</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">System of color wheels for streptomycete taxonomy</article-title><source>Appl Microbiol</source><year>1963</year><volume>11</volume><fpage>335</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1128/am.11.4.335-338.1963</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirling</surname><given-names>ET</given-names></name><name><surname>Gottlieb</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Methods for characterization of Streptomyces species</article-title><source>Int J Syst Bacteriol</source><year>1966</year><volume>16</volume><fpage>313</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1099/00207713-16-3-313</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Szabo, I., and IM, S. (1975). A DIAGNOSTIC KEY FOR THE IDENTIFICATION OF" SPECIES" OF STREPTOMYCES AND STREPTOVERTICILLIUM INCLUDED IN THE INTERNATIONAL STREPTOMYCES PROJET.</mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Awady</surname><given-names>ME</given-names></name><name><surname>Eldin</surname><given-names>MAN</given-names></name><name><surname>Ibrahim</surname><given-names>HM</given-names></name><name><surname>Al Bahnasy</surname><given-names>ME</given-names></name><name><surname>Aziz</surname><given-names>SHA</given-names></name></person-group><article-title xml:lang="en">In vitro evaluation of antioxidant, anticancer, and antiviral activities of exopolysaccharide from Streptomyces hirsutus NRC2018</article-title><source>Journal of Applied Pharmaceutical Science</source><year>2019</year><volume>9</volume><fpage>010</fpage><lpage>018</lpage><pub-id pub-id-type="doi">10.7324/JAPS.2019.91102</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodfellow</surname><given-names>M</given-names></name><name><surname>Lacey</surname><given-names>J</given-names></name><name><surname>Todd</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Numerical classification of thermophilic streptomycetes</article-title><source>Microbiology</source><year>1987</year><volume>133</volume><fpage>3135</fpage><lpage>3149</lpage><pub-id pub-id-type="doi">10.1099/00221287-133-11-3135</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">A nonenzymatic method to isolate genomic DNA from bacteria and actinomycete</article-title><source>Anal Biochem</source><year>2005</year><volume>337</volume><fpage>354</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2004.11.029</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardes</surname><given-names>M</given-names></name><name><surname>Bruns</surname><given-names>TD</given-names></name></person-group><article-title xml:lang="en">ITS primers with enhanced specificity for basidiomycetes-application to the identification of mycorrhizae and rusts</article-title><source>Mol Ecol</source><year>1993</year><volume>2</volume><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1111/j.1365-294X.1993.tb00005.x</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dodgson</surname><given-names>K</given-names></name><name><surname>Price</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">A note on the determination of the ester sulphate content of sulphated polysaccharides</article-title><source>Biochemical Journal</source><year>1962</year><volume>84</volume><fpage>106</fpage><pub-id pub-id-type="doi">10.1042/bj0840106</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filisetti-Cozzi</surname><given-names>TM</given-names></name><name><surname>Carpita</surname><given-names>NC</given-names></name></person-group><article-title xml:lang="en">Measurement of uronic acids without interference from neutral sugars</article-title><source>Anal Biochem</source><year>1991</year><volume>197</volume><fpage>157</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(91)90372-Z</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randall</surname><given-names>R</given-names></name><name><surname>Phillips</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Fractionation and characterization of gum from Acacia senegal</article-title><source>Food Hydrocolloids</source><year>1989</year><volume>3</volume><fpage>65</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/S0268-005X(89)80034-7</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>J</given-names></name><name><surname>Dou</surname><given-names>L</given-names></name><name><surname>Yoshimura</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Ohya</surname><given-names>K</given-names></name><name><surname>Moriarty</surname><given-names>T</given-names></name><name><surname>Emery</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>C-C</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">A polymer tandem solar cell with 10.6% power conversion efficiency</article-title><source>Nat Commun</source><year>2013</year><volume>4</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/ncomms2411</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Polysaccharides from Enteromorpha compressa: Isolation, purification and structural features</article-title><source>Carbohyd Polym</source><year>2006</year><volume>66</volume><fpage>408</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2006.03.027</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingkaninan</surname><given-names>K</given-names></name><name><surname>Temkitthawon</surname><given-names>P</given-names></name><name><surname>Chuenchom</surname><given-names>K</given-names></name><name><surname>Yuyaem</surname><given-names>T</given-names></name><name><surname>Thongnoi</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Screening for acetylcholinesterase inhibitory activity in plants used in Thai traditional rejuvenating and neurotonic remedies</article-title><source>J Ethnopharmacol</source><year>2003</year><volume>89</volume><fpage>261</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2003.08.008</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPhee</surname><given-names>S</given-names></name><name><surname>Hodges</surname><given-names>L</given-names></name><name><surname>Wright</surname><given-names>P</given-names></name><name><surname>Wynne</surname><given-names>P</given-names></name><name><surname>Kalafatis</surname><given-names>N</given-names></name><name><surname>Harney</surname><given-names>D</given-names></name><name><surname>Macrides</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus</article-title><source>Comp Biochem Physiol B: Biochem Mol Biol</source><year>2007</year><volume>146</volume><fpage>346</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.cbpb.2006.11.001</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monserrat</surname><given-names>JM</given-names></name><name><surname>Bianchini</surname><given-names>A</given-names></name><name><surname>Bainy</surname><given-names>ACD</given-names></name></person-group><article-title xml:lang="en">Kinetic and toxicological characteristics of acetylcholinesterase from the gills of oysters (Crassostrea rhizophorae) and other aquatic species</article-title><source>Mar Environ Res</source><year>2002</year><volume>54</volume><fpage>781</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1016/S0141-1136(02)00136-8</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Yi</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds</article-title><source>Eur J Med Chem</source><year>2009</year><volume>44</volume><fpage>1773</fpage><lpage>1778</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2008.04.002</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Larsen, L., Dahl, E., and Bremer, J. (1996). Peroxidative oxidation of leuco-dichlorofluorescein by prostaglandin H synthase in prostaglandin biosynthesis from polyunsaturated fatty acids. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism <italic>1299</italic>, 47–53.</mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>FM</given-names></name><name><surname>Fouad</surname><given-names>R</given-names></name><name><surname>El-Hallouty</surname><given-names>S</given-names></name><name><surname>Hendawy</surname><given-names>SF</given-names></name><name><surname>Omer</surname><given-names>EA</given-names></name><name><surname>Mohammed</surname><given-names>RS</given-names></name></person-group><article-title xml:lang="en">Egyptian Myrtus communis L. Essential oil Potential role as invitro Antioxidant, Cytotoxic and α-amylase Inhibitor</article-title><source>Egypt J Chem</source><year>2021</year><volume>64</volume><fpage>3005</fpage><lpage>3017</lpage></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>NJ</given-names></name><name><surname>Rice-Evans</surname><given-names>CA</given-names></name></person-group><article-title xml:lang="en">The relative contributions of ascorbic acid and phenolic antioxidants to the total antioxidant activity of orange and apple fruit juices and blackcurrant drink</article-title><source>Food Chem</source><year>1997</year><volume>60</volume><fpage>331</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/S0308-8146(96)00339-1</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnao</surname><given-names>MB</given-names></name><name><surname>Cano</surname><given-names>A</given-names></name><name><surname>Acosta</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">The hydrophilic and lipophilic contribution to total antioxidant activity</article-title><source>Food Chem</source><year>2001</year><volume>73</volume><fpage>239</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/S0308-8146(00)00324-1</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gülçin</surname><given-names>I</given-names></name><name><surname>Küfrevioǧlu</surname><given-names>Öİ</given-names></name><name><surname>Oktay</surname><given-names>M</given-names></name><name><surname>Büyükokuroǧlu</surname><given-names>ME</given-names></name></person-group><article-title xml:lang="en">Antioxidant, antimicrobial, antiulcer and analgesic activities of nettle (Urtica dioica L.)</article-title><source>J Ethnopharmacol</source><year>2004</year><volume>90</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2003.09.028</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyaizu</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Antioxidative activities of browning reaction prepared from glucosamine</article-title><source>Jpn J Nutr</source><year>1986</year><volume>44</volume><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.5264/eiyogakuzashi.44.307</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinis</surname><given-names>TC</given-names></name><name><surname>Madeira</surname><given-names>VM</given-names></name><name><surname>Almeida</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers</article-title><source>Arch Biochem Biophys</source><year>1994</year><volume>315</volume><fpage>161</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1006/abbi.1994.1485</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Ooi</surname><given-names>V</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Free radical scavenging activities of mushroom polysaccharide extracts</article-title><source>Life Sci</source><year>1997</year><volume>60</volume><fpage>763</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1016/S0024-3205(97)00004-0</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balakrishnan</surname><given-names>N</given-names></name><name><surname>Panda</surname><given-names>A</given-names></name><name><surname>Raj</surname><given-names>N</given-names></name><name><surname>Shrivastava</surname><given-names>A</given-names></name><name><surname>Prathani</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">The evaluation of nitric oxide scavenging activity of Acalypha indica Linn root</article-title><source>Asian Journal of Research in Chemistry</source><year>2009</year><volume>2</volume><fpage>148</fpage><lpage>150</lpage></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huddleston</surname><given-names>AS</given-names></name><name><surname>Cresswell</surname><given-names>N</given-names></name><name><surname>Neves</surname><given-names>M</given-names></name><name><surname>Beringer</surname><given-names>JE</given-names></name><name><surname>Baumberg</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>DI</given-names></name><name><surname>Wellington</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Molecular detection of streptomycin-producing streptomycetes in Brazilian soils</article-title><source>Appl Environ Microbiol</source><year>1997</year><volume>63</volume><fpage>1288</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.1128/aem.63.4.1288-1297.1997</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Goodwin</surname><given-names>A</given-names></name><name><surname>Lawther</surname><given-names>JM</given-names></name><name><surname>Bolton</surname><given-names>AJ</given-names></name></person-group><article-title xml:lang="en">Fractionation and characterization of polysaccharides from abaca fibre</article-title><source>Carbohyd Polym</source><year>1998</year><volume>37</volume><fpage>351</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/S0144-8617(98)00046-0</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Wan</surname><given-names>F</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Nitrite oxide and inducible nitric oxide synthase were regulated by polysaccharides isolated from Glycyrrhiza uralensis Fisch</article-title><source>J Ethnopharmacol</source><year>2008</year><volume>118</volume><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.03.002</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gitler</surname><given-names>AD</given-names></name><name><surname>Dhillon</surname><given-names>P</given-names></name><name><surname>Shorter</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Neurodegenerative disease: models, mechanisms, and a new hope</article-title><source>DMM</source><year>2017</year><volume>10</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1242/dmm.030205</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Zolezzi, J.M., Bastías-Candia, S., and Inestrosa, N.C. (2018). Molecular basis of neurodegeneration: Lessons from Alzheimer’s and Parkinson’s diseases. In Recent Advances in Neurodegeneration, A. Borreca, ed. (London, UK: IntechOpen).</mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heemels</surname><given-names>MT</given-names></name></person-group><article-title xml:lang="en">Neurodegenerative diseases</article-title><source>Nature</source><year>2016</year><volume>539</volume><fpage>179</fpage><pub-id pub-id-type="doi">10.1038/539179a</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenical</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Natural products chemistry in the marine environment</article-title><source>Science</source><year>1982</year><volume>215</volume><fpage>923</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1126/science.215.4535.923</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Preparation, characterization and immunomodulatory activity of selenium-enriched exopolysaccharide produced by bacterium Enterobacter cloacae Z0206</article-title><source>Biores Technol</source><year>2009</year><volume>100</volume><fpage>2095</fpage><lpage>2097</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2008.10.037</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selim</surname><given-names>MS</given-names></name><name><surname>Amer</surname><given-names>SK</given-names></name><name><surname>Mohamed</surname><given-names>SS</given-names></name><name><surname>Mounier</surname><given-names>MM</given-names></name><name><surname>Rifaat</surname><given-names>HM</given-names></name></person-group><article-title xml:lang="en">Production and characterisation of exopolysaccharide from Streptomyces carpaticus isolated from marine sediments in Egypt and its effect on breast and colon cell lines</article-title><source>Journal of Genetic Engineering and Biotechnology</source><year>2018</year><volume>16</volume><fpage>23</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.jgeb.2017.10.014</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paolo</surname><given-names>M</given-names></name><name><surname>Papi</surname><given-names>L</given-names></name><name><surname>Gori</surname><given-names>F</given-names></name><name><surname>Turillazzi</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Natural products in neurodegenerative diseases: A great promise but an ethical challenge</article-title><source>Int J Mol Sci</source><year>2019</year><volume>20</volume><fpage>5170</fpage><pub-id pub-id-type="doi">10.3390/ijms20205170</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanzione</surname><given-names>P</given-names></name><name><surname>Tropepi</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Drugs and clinical trials in neurodegenerative diseases</article-title><source>Ann Ist Super Sanita</source><year>2011</year><volume>47</volume><fpage>49</fpage><lpage>54</lpage></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apaydin</surname><given-names>H</given-names></name><name><surname>Ertan</surname><given-names>S</given-names></name><name><surname>Özekmekçi</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Broad bean (Vicia faba)—A natural source of L-dopa—Prolongs “on” periods in patients with Parkinson's disease who have “on–off” fluctuations</article-title><source>Movement disorders: official journal of the Movement Disorder Society</source><year>2000</year><volume>15</volume><fpage>164</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1002/1531-8257(200001)15:1&lt;164::AID-MDS1028&gt;3.0.CO;2-E</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greggio</surname><given-names>E</given-names></name><name><surname>Bergantino</surname><given-names>E</given-names></name><name><surname>Carter</surname><given-names>D</given-names></name><name><surname>Ahmad</surname><given-names>R</given-names></name><name><surname>Costin</surname><given-names>GE</given-names></name><name><surname>Hearing</surname><given-names>VJ</given-names></name><name><surname>Clarimon</surname><given-names>J</given-names></name><name><surname>Singleton</surname><given-names>A</given-names></name><name><surname>Eerola</surname><given-names>J</given-names></name><name><surname>Hellström</surname><given-names>O</given-names></name></person-group><article-title xml:lang="en">Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease</article-title><source>J Neurochem</source><year>2005</year><volume>93</volume><fpage>246</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03019.x</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Tang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Boissy</surname><given-names>RE</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation</article-title><source>Proc Natl Acad Sci</source><year>2006</year><volume>103</volume><fpage>353</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1073/pnas.0509822102</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azam</surname><given-names>F</given-names></name><name><surname>Alabdullah</surname><given-names>NH</given-names></name><name><surname>Ehmedat</surname><given-names>HM</given-names></name><name><surname>Abulifa</surname><given-names>AR</given-names></name><name><surname>Taban</surname><given-names>I</given-names></name><name><surname>Upadhyayula</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer’s disease: an investigation by docking, molecular dynamics, and DFT studies</article-title><source>J Biomol Struct Dyn</source><year>2018</year><volume>36</volume><fpage>2099</fpage><lpage>2117</lpage><pub-id pub-id-type="doi">10.1080/07391102.2017.1338164</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>GP</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Chu</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Beech</surname><given-names>W</given-names></name><name><surname>Teter</surname><given-names>B</given-names></name><name><surname>Tran</surname><given-names>T</given-names></name><name><surname>Ubeda</surname><given-names>O</given-names></name><name><surname>Ashe</surname><given-names>KH</given-names></name><name><surname>Frautschy</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease</article-title><source>J Neurosci</source><year>2000</year><volume>20</volume><fpage>5709</fpage><lpage>5714</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-15-05709.2000</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netland</surname><given-names>EE</given-names></name><name><surname>Newton</surname><given-names>JL</given-names></name><name><surname>Majocha</surname><given-names>RE</given-names></name><name><surname>Tate</surname><given-names>BA</given-names></name></person-group><article-title xml:lang="en">Indomethacin Reverses the Microglial Response to Amyloid β-Protein</article-title><source>Neurobiol Aging</source><year>1998</year><volume>19</volume><fpage>201</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/S0197-4580(98)00047-5</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Babu-Khan</surname><given-names>S</given-names></name><name><surname>Vassar</surname><given-names>R</given-names></name><name><surname>Biere</surname><given-names>AL</given-names></name><name><surname>Citron</surname><given-names>M</given-names></name><name><surname>Landreth</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Anti-inflammatory drug therapy alters β-amyloid processing and deposition in an animal model of Alzheimer's disease</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><fpage>7504</fpage><lpage>7509</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-20-07504.2003</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>T</given-names></name><name><surname>Sugeno</surname><given-names>N</given-names></name><name><surname>Takeda</surname><given-names>A</given-names></name><name><surname>Matsuzaki-Kobayashi</surname><given-names>M</given-names></name><name><surname>Kikuchi</surname><given-names>A</given-names></name><name><surname>Furukawa</surname><given-names>K</given-names></name><name><surname>Miyagi</surname><given-names>T</given-names></name><name><surname>Itoyama</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Role of Neu4L sialidase and its substrate ganglioside GD3 in neuronal apoptosis induced by catechol metabolites</article-title><source>FEBS Lett</source><year>2007</year><volume>581</volume><fpage>406</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2006.12.046</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>T</given-names></name><name><surname>Treis</surname><given-names>A</given-names></name><name><surname>Patenge</surname><given-names>N</given-names></name><name><surname>Fiesel</surname><given-names>FC</given-names></name><name><surname>Springer</surname><given-names>W</given-names></name><name><surname>Kahle</surname><given-names>PJ</given-names></name></person-group><article-title xml:lang="en">Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways</article-title><source>J Neurochem</source><year>2008</year><volume>105</volume><fpage>1700</fpage><lpage>1715</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05277.x</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="other">Juneja, K.S. (2006). Tyrosinase-like activity of several Alzheimer's disease related and model peptides and their inhibition by natural antioxidants.</mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>H-S</given-names></name><name><surname>Rho</surname><given-names>H-S</given-names></name><name><surname>Yoo</surname><given-names>J-W</given-names></name><name><surname>Ahn</surname><given-names>S-M</given-names></name><name><surname>Lee</surname><given-names>J-Y</given-names></name><name><surname>Lee</surname><given-names>J-A</given-names></name><name><surname>Kim</surname><given-names>M-K</given-names></name><name><surname>Kim</surname><given-names>D-H</given-names></name><name><surname>Chang</surname><given-names>I-S</given-names></name></person-group><article-title xml:lang="en">The inhibitory effect of new hydroxamic acid derivatives on melanogenesis</article-title><source>Bull Korean Chem Soc</source><year>2008</year><volume>29</volume><fpage>43</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.5012/bkcs.2008.29.1.043</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salah</surname><given-names>NM</given-names></name><name><surname>Souleman</surname><given-names>AM</given-names></name><name><surname>Shaker</surname><given-names>KH</given-names></name><name><surname>Hawary</surname><given-names>S</given-names></name><name><surname>El-Hady</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Acetylcholinesterase, alpha-glucosidase and tyrosinase inhibitors from Egyptian propolis</article-title><source>International Journal of Pharmacognosy Phytochemistry Research</source><year>2017</year><volume>9</volume><fpage>528</fpage><lpage>536</lpage></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobine</surname><given-names>D</given-names></name><name><surname>Sadeer</surname><given-names>N</given-names></name><name><surname>Jugreet</surname><given-names>S</given-names></name><name><surname>Suroowan</surname><given-names>S</given-names></name><name><surname>Keenoo</surname><given-names>BS</given-names></name><name><surname>Imran</surname><given-names>M</given-names></name><name><surname>Venugopala</surname><given-names>KN</given-names></name><name><surname>Ibrahim</surname><given-names>FM</given-names></name><name><surname>Zengin</surname><given-names>G</given-names></name><name><surname>Mahomoodally</surname><given-names>MF</given-names></name></person-group><article-title xml:lang="en">Potential of medicinal plants as neuroprotective and therapeutic properties against amyloid-β-related toxicity, and glutamate-induced excitotoxicity in human neural cells</article-title><source>Curr Neuropharmacol</source><year>2021</year><volume>19</volume><fpage>1416</fpage><pub-id pub-id-type="doi">10.2174/1570159X19666210412095251</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roseiro</surname><given-names>LB</given-names></name><name><surname>Rauter</surname><given-names>AP</given-names></name><name><surname>Serralheiro</surname><given-names>MLM</given-names></name></person-group><article-title xml:lang="en">Polyphenols as acetylcholinesterase inhibitors: structural specificity and impact on human disease</article-title><source>Nutrition and Aging</source><year>2012</year><volume>1</volume><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.3233/NUA-2012-0006</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="other">Firdaus, Z., Singh, N., Prajapati, S.K., Krishnamurthy, S., and Singh, T.D. (2020). Centella asiatica prevents D-galactose-Induced cognitive deficits, oxidative stress and neurodegeneration in the adult rat brain. Drug Chem Toxicol, 1–10.</mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jesus Raposo</surname><given-names>MF</given-names></name><name><surname>De Morais</surname><given-names>RMSC</given-names></name><name><surname>de Morais</surname><given-names>AMMB</given-names></name></person-group><article-title xml:lang="en">Bioactivity and applications of sulphated polysaccharides from marine microalgae</article-title><source>Mar Drugs</source><year>2013</year><volume>11</volume><fpage>233</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.3390/md11010233</pub-id></mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>AK</given-names></name><name><surname>Laroche</surname><given-names>C</given-names></name><name><surname>Marcati</surname><given-names>A</given-names></name><name><surname>Ursu</surname><given-names>AV</given-names></name><name><surname>Jubeau</surname><given-names>S</given-names></name><name><surname>Marchal</surname><given-names>L</given-names></name><name><surname>Petit</surname><given-names>E</given-names></name><name><surname>Djelveh</surname><given-names>G</given-names></name><name><surname>Michaud</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Separation and fractionation of exopolysaccharides from Porphyridium cruentum</article-title><source>Biores Technol</source><year>2013</year><volume>145</volume><fpage>345</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2012.12.038</pub-id></mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname><given-names>L</given-names></name><name><surname>Grenha</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Sulfated seaweed polysaccharides as multifunctional materials in drug delivery applications</article-title><source>Mar Drugs</source><year>2016</year><volume>14</volume><fpage>42</fpage><pub-id pub-id-type="doi">10.3390/md14030042</pub-id></mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>IW</given-names></name></person-group><article-title xml:lang="en">Microbial exopolysaccharides-structural subtleties and their consequences</article-title><source>Pure Appl Chem</source><year>1997</year><volume>69</volume><fpage>1911</fpage><lpage>1918</lpage><pub-id pub-id-type="doi">10.1351/pac199769091911</pub-id></mixed-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="other">Ohno, N., Nameda, S., Harada, T., Miura, N.N., Adachi, Y., Nakajima, M., Yoshida, K., Yoshida, H., and Yadomae, T. (2003). Immunomodulating Activity of a b-Glucan Preparation, SCG, Extracted from a Culinary–Medicinal Mushroom, Sparassis crispa Wulf.: Fr.(Aphyllophoromycetideae), and Application to Cancer Patients. International Journal of Medicinal Mushrooms <italic>5</italic>.</mixed-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">Feng, Y., and Wang, X. (2012). Antioxidant therapies for Alzheimer's disease. Oxidative medicine and cellular longevity <italic>2012</italic>.</mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNaull</surname><given-names>BBA</given-names></name><name><surname>Todd</surname><given-names>S</given-names></name><name><surname>McGuinness</surname><given-names>B</given-names></name><name><surname>Passmore</surname><given-names>AP</given-names></name></person-group><article-title xml:lang="en">Inflammation and anti-inflammatory strategies for Alzheimer’s disease–a mini-review</article-title><source>Gerontology</source><year>2010</year><volume>56</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1159/000237873</pub-id></mixed-citation></ref></ref-list></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>EPS</term><def><p id="Par4">Exopolysaccharides</p></def></def-item><def-item><term>°C</term><def><p id="Par5">Degree Celsius</p></def></def-item><def-item><term>mg</term><def><p id="Par6">Milligram</p></def></def-item><def-item><term>µg</term><def><p id="Par7">Microgram</p></def></def-item><def-item><term>ml</term><def><p id="Par8">Milliliter</p></def></def-item><def-item><term>FTIR</term><def><p id="Par9">Fourier-transform infrared</p></def></def-item><def-item><term>HPGPC</term><def><p id="Par10">High-performance gel permeation chromatography</p></def></def-item><def-item><term>HPLC</term><def><p id="Par11">High-performance liquid chromatography</p></def></def-item><def-item><term>DPPH</term><def><p id="Par12">1,1-Diphenyl-2-picryl-hydrazyl</p></def></def-item><def-item><term>BHT</term><def><p id="Par13">Butylated hydroxytoluene</p></def></def-item><def-item><term>ABTS</term><def><p id="Par14">2, 2-Azino-bis (3-ethylbenz-thiazoline-6-sulfonic acid)</p></def></def-item><def-item><term>NADH</term><def><p id="Par15">Nicotinamide adenine dinucleotide</p></def></def-item><def-item><term>NBT</term><def><p id="Par16">Nitroblue tetrazolium</p></def></def-item><def-item><term>PMS</term><def><p id="Par17">Phenazine methosulphate</p></def></def-item><def-item><term>SNP</term><def><p id="Par18">Sodium nitroprusside</p></def></def-item><def-item><term>TCA</term><def><p id="Par19">Trichloroacetic acid</p></def></def-item><def-item><term>ROS</term><def><p id="Par20">Reactive Oxygen Species</p></def></def-item><def-item><term>DTNB</term><def><p id="Par21">5,5-Dithiobis(2-nitrobenzoic acid)</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Bioinformatics</facet-value><facet-value count="1">Biomedical Engineering and Bioengineering</facet-value><facet-value count="1">Biotechnology</facet-value><facet-value count="1">Engineering</facet-value><facet-value count="1">Genetic Engineering</facet-value><facet-value count="1">Genetics and Genomics</facet-value><facet-value count="1">Proteomics</facet-value></facet><facet name="keyword"><facet-value count="1">
                        Streptomyces
                     </facet-value><facet-value count="1">Anti-Alzheimer</facet-value><facet-value count="1">Anti-inflammatory</facet-value><facet-value count="1">Anti-tyrosinase</facet-value><facet-value count="1">Antioxidant</facet-value><facet-value count="1">Exopolysaccharide</facet-value></facet><facet name="pub"><facet-value count="1">Journal of Genetic Engineering and Biotechnology</facet-value></facet><facet name="year"><facet-value count="1">2023</facet-value></facet><facet name="country"><facet-value count="1">Egypt</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
